{
    "id": "yago_30347_3",
    "rank": 13,
    "data": {
        "url": "https://rbm.q2labsolutions.com/biomarker-detail/tn-c-human",
        "read_more_link": "",
        "language": "en",
        "title": "TN",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://rbm.q2labsolutions.com/hs-fs/hubfs/RBM%20images/Rules_Based_Medicine_Endorsed_Logo_RGB.png?width=256&height=32&name=Rules_Based_Medicine_Endorsed_Logo_RGB.png",
            "https://rbm.q2labsolutions.com/hs-fs/hubfs/Q2%20Solutions%20white.png?width=175&height=28&name=Q2%20Solutions%20white.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/hubfs/RBM%20images/Website/rbm-favicon.png",
        "meta_site_name": "",
        "canonical_link": "https://rbm.q2labsolutions.com/biomarker-detail/tn-c-human",
        "text": "Bibliography\n\nSmoking changes adaptive immunity with persistent effects (2024) Violaine Saint-Andr?, Bruno Charbit3, Anne Biton, Vincent Rouilly, C?line Poss?m?, Anthony Bertrand, Maxime Rotival, Jacob Bergstedt, Etienne Patin, Matthew L. Albert, Lluis Quintana-Murci, Darragh Duffy Nature\n\nmedical_services Therapy Indications\n\nCedirogant Population Pharmacokinetics and Pharmacodynamic Analyses of Interleukin-17A Inhibition in Two Phase I Studies in Healthy Participants and Participants with Moderate to Severe Psoriasis (2024) Corinna S Maier, Doerthe Eckert, F Stephen Laroux, Kinjal M Hew, Ahmed A Suleiman, Wei Liu, Mohamed-Eslam F Mohamed Clin Pharmacol Drug Dev\n\nmedical_services Therapy Indications\n\nLow testosterone levels relate to poorer cognitive function in women in an APOE-e4-dependant manner (2024) Melanie A Dratva, Sarah J Banks, Matthew S Panizzon, Douglas Galasko, Erin E Sundermann Biology of Sex Differences\n\nmedical_services Therapy Indications\n\nPrediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial (2024) Thomas Seufferlein, Ludwig Lausser, Alexander Stein, Dirk Arnold, Gerald Prager, Stefan Kasper-Virchow, Michael Niedermeier, Lothar M?ller, Stefan Kubicka, Alexander K?nig, Petra B?chner-Steudel, Kai Wille, Andreas W Berger, Angelika M R Kestler, Johann M Kraus, Silke D Werle, Lukas Perkhofer, Thomas J Ettrich, Hans A Kestler Plos One\n\nmedical_services Therapy Indications\n\nProteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study (2024) Jonah F. Byrne, Colm Healy, Melanie F?cking, Subash Raj Susai, David Mongan, Kieran Wynne, Eleftheria Kodosaki, Meike Heurich, Lieuwe de Haan, Ian B. Hickie, Stefan Smesny, Andrew Thompson, Connie Markulev, Alison Ruth Young, Miriam R. Sch?fer, Anita Riecher-R?ssler, Nilufar Mossaheb, Gregor Berger, Monika Schl?gelhofer, Merete Nordentoft, Eric Y.H. Chen, Swapna Verma, Dorien H. Nieman, Scott W. Woods, Barbara A. Cornblatt, William S. Stone, Daniel H. Mathalon, Carrie E. Bearden, Kristin S. Cadenhead, Jean Addington, Elaine F. Walker, Tyrone D. Cannon, Mary Cannon, Pat McGorry, Paul Amminger, Gerard Cagney, Barnaby Nelson, Clark Jeffries, Diana Perkins, and David R. Cotter Schizophrenia Bulletin\n\nmedical_services Therapy Indications\n\nPlant stanol consumption increases anti-COVID-19 antibody responses, independent of changes in serum cholesterol concentrations: a randomized controlled trial (2024) Lieve van Brakel, Ronald P Mensink, Dieter L?tjohann, Jogchum Plat The Americal Journal of Clinical Nutrition\n\nmedical_services Therapy Indications\n\nWhole-blood culture-derived cytokine combinations for the diagnosis of tuberculosis (2024) Anne Ahrens ?stergaard, S?ren Feddersen, Mike B. Barnkob, Rasmus Bank Lynggaard, Amanda Cecilie Annie Karstoft, Maria Borup, Ingrid Louise Titlestad, Torben Tranborg Jensen, Ole Hilberg, Christian Wejse, Stephanie Bjerrum, Morten Blaabjerg, Kristian Assing, Isik Somuncu Johansen Frontiers in Immunology\n\nmedical_services Therapy Indications\n\nInterferon-Gamma-Release assay and absolute CD8 lymphocyte count for acquired immunosuppression monitoring in critically ill patients (2024) Muzhda Haem Rahimi, Fabienne Venet, Anne-Claire Lukaszewicz, Estelle Peronnet, Elisabeth Cerrato, Thomas Rimmel?, Guillaume Monneret Cytokine\n\nmedical_services Therapy Indications\n\nA Human Whole Blood Culture System Reveals Detailed Cytokine Release Profiles of Implant Materials (2024) Sascha Niclas Klimosch, Marbod Weber, Jordi Caball?-Serrano, Thomas Knorpp, Antonio Munar-Frau, Birgit Margareta Schaefer, Manfred Schmolz Medical Devices: Evidence and Research\n\nmedical_services Therapy Indications\n\nWhole blood stimulation provides preliminary evidence of altered immune function following SRC (2024) Alex P. Di Battista, Shawn G. Rhind, Maria Shiu and Michael G. Hutchison BMC Immunology\n\nmedical_services Therapy Indications\n\nAn Exploratory Study of Early Immune Response Markers for Pembrolizumab in Urothelial Tract Cancer (2024) Dag Rune Stormoen ,Lise H?j Omland,Kent William Mouw,Zoltan Szallasi,Sisse Rye Ostrowski, Susanne Dam Nielsen and Helle Pappot Uro\n\nmedical_services Therapy Indications\n\nBetaine and L-Carnitine Synergistically Influence the Metabolome and Immune Response in Dogs (2024) Dennis E. Jewell, Selena K. Tavener, Renea Creech and Kiran S. Panickar Animals\n\nmedical_services Therapy Indications\n\nA phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome (2024) Terese C. Hammond, Marco A. Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow4, Heather Daley, Kit Shaw, Koen van Besien, Alexandra Gomez-Arteaga, Don Stevens, WaldoOrtuzar, Xavier Michelet, Rachel Smith, Darrian Moskowitz, Reed Masakayan, Burcu Yigit, Shannon Boi, Kah Teong Soh, John Chamberland, Xin Song, Yu Qin, Ilya Mishchenko, Maurice Kirby, Valeriia Nasonenko, Alexa Buffa, Jennifer S. Buell, Dhan Chand, Marc van Dijk, Justin Stebbing & Mark A. Exley Nature Communications\n\nmedical_services Therapy Indications\n\nImmune cell populations and induced immune responses at admission in patients hospitalized with vaccine breakthrough SARS-CoV-2 infections (2024) Adin Sejdic, Hans Jakob Hartling, Jon Gitz Holler, Lars Klingen Gj?rde 4, Birgitte Lindegaard, Arnold Matovu Dungu, Filip Gnesin, Maria Elizabeth Engel M?ller, Rebecca Svanberg Teglgaard, Carsten Utoft Niemann, Patrick Terrence Brooks, Charlotte Sv?rke J?rgensen, Kristina Tr?holt Franck, Thea K Fischer, Hanne Vibeke Marquart, Zitta Barrella Harboe, Sisse Rye Ostrowski Frontiers in Immunology\n\nmedical_services Therapy Indications\n\nRegorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study (2023) Marwan Fakih, Kanwal Pratap Singh Raghav, David Z. Chang, Tim Larson, Allen L. Cohn, Timothy K. Huyck, David Cosgrove, Joseph A. Fiorillo, Rachel Tam, David D?Adamo, Neelesh Sharma, Barbara J. Brennan, Ying A. Wang,k Sabine Coppieters, Hong Zebger-Gong, Anke Weispfenning,m Henrik Seidel, Bart A. Ploeger,m Udo Mueller, Carolina Soares Viana de Oliveira, and Andrew Scott Paulsono eClinicalMedicine\n\nmedical_services Therapy Indications\n\nA phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer (2023) Ernest Nadal, Mansoor Saleh , Santiago Ponce Aix , Maria Ochoa de Olza, Sandip Pravin Patel , Scott Antonia, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T. Estrem, Jiangang Liu, Emin Avsar, Wen Hong Lin, Karim A. Benhadji, Leena Gandhi, Susan C. Guba and Inmaculada Ales Diaz BMC Cancer\n\nmedical_services Therapy Indications\n\nUrinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis (2023) Ahmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris III, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gabor G Illei, S Sam Lim , Wendy I White Lupis Science and Medicine\n\nmedical_services Therapy Indications\n\nEarly and recent exposure to adversity, TLR-4 stimulated inflammation, and diurnal cortisol in women with interstitial cystitis/bladder pain syndrome: A MAPP research network study (2023) Susan K Lutgendorf, Sharaf Zia, Yi Luo, Michael ODonnell, Adrie van Bokhoven, Catherine S Bradley, Robert Gallup, Jennifer Pierce, Bayley J Taple, Bruce D Naliboff, J Quentin Clemens, Karl J Kreder, Andrew Schrepf Brain, Behavior, and Immunity\n\nmedical_services Therapy Indications\n\nFirst-in-human study of E7130 (a tumor microenvironment-ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose-escalation part (2023) Toshihiko Doi MD, PhD, Nobuaki Matsubara MD, Yoichi Naito MD, Yasutoshi Kuboki MD, Kenichi Harano MD, Makiko Ono MD, PhD, Tetsuya Urasaki MD, PhD, Akihiro Ohmoto MD, PhD, Tsubasa Kawanai MSc, Takashi Hisai MSc, Hiroki Ikezawa MSc, Sari Shiba MSc, Ken Ito PhD, Taro Semba MSc, Osamu Asano PhD, Shunji Takahashi MD, PhD Cancer\n\nmedical_services Therapy Indications\n\nEvaluation of BMS-986142, a reversible Brutons tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging -ranging, placebo controlled, adaptive design study (2023) Philip G Conaghan, Miroslawa Nowak, Shuyan Du, Yi Luo, Jessica Landis, Chahin Pachai, Aberra Fura, Ian M Catlett, Dennis M Grasela, Mikkel ?stergaard Rheumatoloty\n\nmedical_services Therapy Indications\n\nTezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (2023) Tanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, Joseph K Han, Nicole Journal of Asthma and Allergy\n\nmedical_services Therapy Indications\n\nLevels of iron and iron-related proteins in Alzheimers disease: a systematic review and meta-analysis (2023) Lin Gong, Jiahui Sun, Shuyan Cong Journal of Trace Elements in Medicine and Biology\n\nmedical_services Therapy Indications\n\nIdentification of molecular subphenotypes in two cohorts of paediatric ARDS (2023) Nadir Yehya , Matt S Zinter , Jill M Thompson, Michelle J Lim, Mark R Hanudel, Mustafa F Alkhouli, Hector Wong, Matthew N Alder,Daniel J McKeone, E Scott Halstead, Pratik Sinha, Anil Sapru5 Thorax\n\nmedical_services Therapy Indications\n\nComprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial (2023) Steffan T. Nawrocki, Julian Olea, Claudia Villa Celi, Homa Dadrastoussi,Kaijin Wu, Denice Tsao-Wei, Anthony Colombo, Matt Coffey, Eduardo Fernandez Hernandez, Xuelian Chen, Gerard J. Nuovo, Jennifer S. Carew, Ann F. Mohrbacher, Paul Fields, Peter Kuhn, Imran Siddiqi, Akil Merchant, and Kevin R. Kelly Clinical Cancer Research\n\nmedical_services Therapy Indications\n\nEffect of anterior quadratus lumborum block with ropivacaine on the immune response after laparoscopic surgery in colon cancer: a substudy of a randomized clinical (2023) Lukas Balsevicius, Paulo C M Urbano, Rune Petring Hasselager, Ahmed Abdirahman Mohamud, Maria Olausson, Melina Svraka, Kirsten L Wahlstr?m, Carolin Oppermann, Dilara Seyma G?genur, Emma Rosenkrantz H?lmich, Britt Cappelen, Susanne Gj?rup S?kmose, Katrine Tanggaard, Thomas Litman, Jens B?rglum, Susanne Brix, Ismail G?genur Reg Anesth Pain Med\n\nmedical_services Therapy Indications\n\nEnabling the evaluation of COVID-19 vaccines with correlates of protection (2023) Arnaud Marchant, Pierre Van Damme, Stanley Plotkin, Pieter Neels, Maria Cristina Cassetti, Jakob Cramer, Marion F. Gruber, David Goldblatt, Deborah King, Wendy Hartig-Merkel, Joris Vandeputte Biologicals\n\nmedical_services Therapy Indications\n\nEffect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial (2023) Elizabeth A. Brown, Anne Minnich, Arun J. Sanyal, Rohit Loomba, Shuyan Du, John Schwarz, Richard L. Ehman, Morten Karsdal, Diana J. Leeming, Giovanni Cizza, Edgar D. Charles JHEP Reports\n\nmedical_services Therapy Indications\n\nElevated Levels of the Cytokine LIGHT in Pediatric Crohns Disease (2023) Christopher J Cardinale, Debra J Abrams, Frank D Mentch, John A Cardinale, Xiang Wang, Charlly Ka, Patrick M A Sleiman, Hakon Hakonarson Journal of Immunology\n\nmedical_services Therapy Indications\n\nInflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD (2023) Stefanie Lerche, Milan Zimmermann, Benjamin Roeben, Isabel Wurster, , Franca Laura Fries, Christian Deuschle, Katharina Waniek, Ingolf Lachmann, Meike Jakobi, Thomas O. Joos, Thomas Knorpp, Nicole Schneiderhan-Marra and Kathrin Brockmann Nature\n\nmedical_services Therapy Indications\n\nTarget occupancy biomarker assay development using a conformation-selective antibody against small-molecule-bound TNF (2023) Elizabeth S Hickford, James O?Connell , Alison Maloney, Peter Florian, Geoffrey I Bioanalysis\n\nmedical_services Therapy Indications\n\nFocused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humans (2023) Stavros Zanos, Despoina Ntiloudi, John Pellerito, Richard Ramdeo, John Graf, Kirk Wallace, Victoria Cotero, Jeff Ashe, Jessica Moon, Meghan Addorisio, David Shoudy, Thomas R. Coleman, Michael Brines, Chris Puleo, Kevin J. Tracey, Sangeeta S. Chavan Brain Stimulation\n\nmedical_services Therapy Indications\n\nPeripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline (2023) Neel H. Mehta, Liangdong Zhou, Yi Li, Laura Beth McIntire, Anna Nordvig, Tracy Butler, Mony de Leon & Gloria C. Chiang Nature\n\nmedical_services Therapy Indications\n\nPhase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas (2023) Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Thomas F Gajewski, Martin Gutierrez, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Elisabeth I Heath, John A Thompson, Sahar Ansari, Celine Jacquemont, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, Juneko E Grilley-Olson Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nAssociations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers?In cognitively unimpaired older adults (2023) Elettra Capogna, Leiv Otto Watne, ?ystein S?rensen, Carlijn Jamila Guichelaar, Ane Victoria Idland, Nathalie Bodd Halaas, Kaj Blennow, Henrik Zetterberg, Kristine Beate Walhovd, Anders Martin Fjell, Didac Vidal-Pi?eiro Brain Behavior Immunology\n\nmedical_services Therapy Indications\n\nPhase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer (2023) Sheena Bhalla, FarjanaJ. Fattah, Chul Ahn, Jessica Williams, Alyssa Macchiaroli, Jonathan Padro, Mereth Pogue, Jonathan E. Dowell, William C. Putnam, Nigel McCracken, David Micklem, Rolf, A. Brekken, David E. Gerber Lung Cancer\n\nmedical_services Therapy Indications\n\nLong-term in vivo vitamin D3 supplementation modulates bovine IL-1 and chemokine responses (2023) Cian Reid , Susana Flores-Villalva, Aude Remot, Emer Kennedy, Cliona O?Farrelly Nature\n\nmedical_services Therapy Indications\n\nCharacterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder (2023) Kasper Recourt, Peter de Boer, Peter van der Ark, Heike Benes, Joop M A van Gerven, Marc Ceusters, Luc van Nueten, Wayne C Drevets, Anindya Bhatacharya, Michael Browning, Gabriel E Jacobs Translational Psychiatry\n\nmedical_services Therapy Indications\n\nBiomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study (2023) Tushar Sood, Nicolas Perrot, Michael Chong, Pedrum Mohammadi-Shemirani, Maha Mushtaha, Darryl Leong, Sumathy Rangarajan, Sibylle Hess, Salim Yusuf, Hertzel C Gerstein, Guillaume Par?, Marie Pigeyre JAMA Network\n\nmedical_services Therapy Indications\n\nQuantifying the spatial clustering characteristics of radiographic emphysema explains variability in pulmonary function (2023) Brian E. Vestal, Debashis Ghosh, Ra?l San Jos? Est?par, Katerina Kechris, Nature\n\nmedical_services Therapy Indications\n\nEvaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1 (2023) Jennifer Leohr and Maria C. Kjellsson CPT: Pharmacometrics & Systems Pharmacology\n\nmedical_services Therapy Indications\n\nClinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma (2023) Shadi Chamseddine, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Clinical Translational Research\n\nmedical_services Therapy Indications\n\nTyrosine kinase signaling-independent MET-targeting with CAR-T cells (2023) Anna Qin1, Yuan Qin1, Joseph Lee2, Anna Anna Qin, Yuan Qin1, Joseph Lee, Anna Musket, Mingyao Ying, Giedre Krenciute, Francesco M. Marincola5, Journal of Translational Medicine\n\nmedical_services Therapy Indications\n\nIdentification of an APOE e4?specific blood-based molecular pathway for Alzheimers disease risk (2023) Qiushan TaoMD, Chao Zhang PhD, Gustavo MercierMD, PhD, Kathryn Lunetta, Ting Fang Alvin AngMD, Samia Akhter-Khan MS Zhengrong Zhang PhD, Andrew Taylor PhD, Ronald J. Killiany PhD, Alzheimer?s & Dementia: Diagnosis, Assessment & DiseaseMonitoring\n\nmedical_services Therapy Indications\n\nSex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia Experiences from the Outcome Reduction with an Initial Glargine (2023) Anne Wang, Sibylle Hess, Shun Fu Lee, Hertzel C. Gerstein Diabetes Res Clin Pract\n\nmedical_services Therapy Indications\n\nIRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial (2023) Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli, Howard Schwartz, Brian J. Feinstein, Phillip La Stella, Afsaneh Alavi, Ashwin Gollerkeri, Jeffrey Davis, Veronica Campbell, Alice McDonald, Sagar Agarwal, Rahul Karnik, Kelvin Shi, Aimee Mishkin, Jennifer Culbertson, Christine Klaus, Bradley Enerson, Virginia Massa, Eric Kuhn, Kirti Sharma, Erin Keaney, Randy Barnes, Dapeng Chen, Xiaozhang Zheng, Haojing Rong, Vijay Sabesan, Chris Ho Nello Mainolfi, Anthony Slavin & Jared A. Gollob Nature Medicine\n\nmedical_services Therapy Indications\n\nA randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients (2023) Barbara Klughammer, Luca Piali, Alexandra Nica, Sandra Nagel, Lorna Bailey, Christoph Jochum, Stanislav Ignatenko, Angela Bl?uer,Sabrina Danilin, Pratiksha Gulati, Joanne Hayward, Petar Scepanovic, Jitao David Zhang, Satish Bhosale, Chui Fung Chong, Andreas Christ Clinical and Translational Medicine\n\nmedical_services Therapy Indications\n\nSeladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis (2023) Andreas E. Kremer, Marlyn J. Mayo, Gideon M. Hirschfield, Cynthia Levy, Christopher L. Bowlus, David E. Jones, Jeff D. Johnson, Charles A. McWherter, Yun-Jung Choi Hepatology\n\nmedical_services Therapy Indications\n\nWhole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate (2022) De Rosa SC, Cohen KW, Bonaparte M, Fu B, Garg S, Gerard C, Goepfert PA, Huang Y, Larocque D, McElrath MJ, Morris d, Van der Most R, de Bruyn G, Anke Pagnon Clinical & Translational Immunology\n\nmedical_services Therapy Indications\n\nCellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study (2022) Kister I, Patskovsky Y, Curtin R, Pei J, Perdomo K, Rimler Z, Voloshyna I, Samanovic MI, Cornelius AR, Velmurugu Y, Nyovanie S, Kim J, Tardio E, Bacon TE, Zhovtis L, Ryerson LZ, Raut P, Pedotti R, Hawker K, Raposo C, Priest J, Cabatingan M, Winger RC, Mulligan MJ, Krogsgaard M, Silverman GJ medRxiv\n\nmedical_services Therapy Indications\n\nT cell apoptosis characterizes severe Covid-19 disease (2022) Andre S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butauz A, Soundaramourty C, Santa Cruz A, Mendes-Frias A, Gotti C, Leclercq M, Nicolas A, Tauzin A, Carvalho A, Capela c, Pedrosa J, Castro AG, Kundura L, Loubet P, Sotto A, Muller L, Lefrant JY, Roger C, Claret PG, Duvnjak S, Tran TA, Racine G, zghidi-Abouzid O, Nioche P, Silvestre R, Droit A, Mammano F, Corbeau P, Estaquier J CDD Press\n\nmedical_services Therapy Indications\n\nEarly stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients (2022) Rebecka Svanberg, Cameron MacPherson, Adrian Zucco, Rudi Agius, Tereza Faitova, Michael Asger Andersen, Caspar da Cunha-Bang, Lars Klingen Gj?rde, Maria Elizabeth Engel M?ller, Patrick Terrence Brooks, Birgitte Lindegaard, Adin Sejdic, Anne Ortved Gang, Ditte Stampe Hersby, Christian Brieghel, Susanne Dam Nielsen, Daria Podlekareva, Annemette Hald, Jakob Thaning Bay, Hanne Marquart, Jens Lundgren, Anne-Mette Lebech, Marie Helleberg, Carsten Utoft Niemann & Sisse Rye Ostrowski Communications Medicine\n\nmedical_services Therapy Indications\n\nDefective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity (2022) Nika?a Smith, C?line Poss?m?, Vincent Bondet, Jamie Sugrue, Liam Townsend, Bruno Charbit, Vincent Rouilly, Violaine Saint-Andr?, Tom Dott, Andre Rodriguez Pozo, Nader Yatim, Olivier Schwartz, Minerva Cervantes-Gonzalez, Jade Ghosn, Paul Bastard, Jean Laurent Casanova, Tali-Anne Szwebel, Benjamin Terrier, Niall Conlon, Cliona OFarrelly, Cl?ona N? Cheallaigh, Nollaig M Bourke, Darragh Duffy Nature Communciations\n\nmedical_services Therapy Indications\n\nPeripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-na?ve schizophrenia (2022) Santiago G. Lago, Jakub Tomasik, Geertje F. Rees, Nitin Rustogi, Javier Vazquez-Bourgon, Sergi Papiol, Paula Suarez-Pinilla, Benedicto Crespo-Facorro, Sabine Bahn Brain Behavior and Immunity\n\nmedical_services Therapy Indications\n\n3Repetitive xenon treatment improves post-stroke sensorimotor and neuropsychiatric dysfunction (2022) Dandekar MP, Yin X, Peng T, Devaraj S, Moarles R, McPherson DD, Huang S Journal of Affective Disorders\n\nmedical_services Therapy Indications\n\nFour groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study (2022) Wesolowska-Andersen A, Brorsson CA, Bizzotto R, Mari A, Tura A, Koivula R, Mahajan A, Vinuela A, Tajes JF, Sharma S, Haid M, Prehn C, Artati A, Hong M, Musholt PB, Kurbasic A, De Masi F, Tsirigos K, Pedersen HK, Gudmundsdottir V, Thomas CE, Banasik K, Jennison C, Jones A, Kennedy G, Bell J, Thomas L, Frost G, Thomsen H, Allin K, Hansen TH, Vestergaard H, Hansen T, Rutters F, Elders P, tHart L, Bonnefond A, Canouil M, Brage S, Kokkola T, Heggie A, McEvoy D Cell Reports Medicine\n\nmedical_services Therapy Indications\n\nDissection of depression heterogeneity using proteomic clusters (2022) van Haeringen M, Milaneschi Y, Lamers F, Penninx BWJH, Jansen R Psychological Medicine\n\nmedical_services Therapy Indications\n\nAntibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment (2022) Bagri A, de Assis RR, Tsai CT, Simmons G, Mei ZW, Von Goetz M, Gatmaitan M, Stone M, Di Germanio C, Martinelli R, Darst O, Rioveros J, Robinson PV, Ward D, Ziman A, Settel D, Khan S, Busch MP, Felgner PL, Corash LM Transfusion\n\nmedical_services Therapy Indications\n\nPlatelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers (2022) Arunima Kapoor, Daniel A Nation Cerebral Circulation - Cognition and Behavior\n\nmedical_services Therapy Indications\n\nMeta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin (2022) Christina B. Joseph, Marta Mariniello, Ayumi Yoshifuji, Guglielmo Schiano, Jennifer Lake, Jonathan Marten, Anne Richmond, Jennifer E. Huffman, Archie Campbell, Sarah E. Harris, Stephan Troyanov, Massimiliano Cocca, Antonietta Robino, S?bastien Th?riault, Kai-Uwe Eckardt, Matthias Wuttke, Yurong Cheng, Tanguy Corre, Ivana Kolcic, Corrinda Black, Vanessa Bruat, Maria Pina Concas, Cinzia Sala, Stefanie Aeschbacher, Franz Schaefer, Sven Bergmann, Harry Campbell, Matthias Olden, Ozren Polasek, David J. Porteous, Ian J. Deary, Francois Madore, Philip Awadalla, Giorgia Girotto, Sheila Ulivi, David Conen, Elke Wuehl, Eric Olinger, James F. Wilson, Murielle Bochud, Anna K?ttgen, Caroline Hayward and Olivier Devuyst Journal of the American Society of Nephrology\n\nmedical_services Therapy Indications\n\nLow T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients (2022) Marion Cremoni, S?bastien Cuozzo, Emanuela Martinuzzi, Susana Barbosa, Nadia Ben Hassen, Filippo Massa, Elisa Demonchy, Matthieu Durand, Olivier Thaunat, Vincent Esnault, Moglie Le Quintrec, Sophie Caillard, Nicolas Glaichenhaus, and Antoine Sicard Viruses\n\nmedical_services Therapy Indications\n\nBiomarker Changes in Response to a 12-Week Supplementation of an Oral Nutritional Supplement Enriched with Protein, Vitamin D and HMB in Malnourished Community Dwelling Older Adults with Sarcopenia (2022) Suzette L. Pereira , Marni E. Shoemaker, Susan Gawel, Gerard J. Davis Menghua Luo, Vikkie A. Mustad and Joel T. Cramer Nutrients\n\nmedical_services Therapy Indications\n\nPregnancy tailors endotoxin-induced monocyte and neutrophil responses in the maternal circulation (2022) Marcelo Farias-Jofre, Roberto Romero, Jose Galaz, Yi Xu, Li Tao, Catherine Demery-Poulos, Marcia Arenas-Hernandez, Gaurav Bhatti, Zhenjie Liu, Naoki Kawahara, Tomi Kanninen, Zachary Shaffer, Tinnakorn Chaiworapongsa, Kevin R. Theis, Adi L. Tarca & Nardhy Gomez-Lopez Inflammation Research\n\nmedical_services Therapy Indications\n\nPre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial (2022) Silje Endresen Reme, Alice Munk, Marianne Therese Smogeli Holter, Ragnhild S. Falk, Henrik B?rsting Jacobsen Plos One\n\nmedical_services Therapy Indications\n\nAnti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena (2022) Anita Borski, Farsad Eskandary, Susanne Haindl, Konstantin Doberer, Jakob M?hlbacher, Katharina A Mayer, Klemens Budde, Philip F Halloran, Edward Chong, Bernd Jilma, Georg A B?hmig, Markus Wahrmann Transplantation\n\nmedical_services Therapy Indications\n\nCC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-infammatory cytokine production (2022) Rajula Gaur, Kofi A Mensah, Jason Stricker, Mary Adams, Anastasia Parton, Dorota Cedzik 1, Jamie Connarn 1, Michael Thomas, Gerald Horan, Peter Schafer, Stuart Mair, Maria Palmisano, Francisco Ram?rez-Valle Arthritis Research and Therapy\n\nmedical_services Therapy Indications\n\nExploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study (2022) Rosa Maja M?hring Gynthersen, Mathilde Orbaek, Helene Mens, Christian Stenor, Lothar Wiese, Sisse Rye Ostrowski, Susanne Dam Nielsen, Anne-Mette Lebech Ticks and Tick-borne Diseases\n\nmedical_services Therapy Indications\n\nPlasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology (2022) Keun You Kim, Junghee Ha, Minae Kim, So Yeon Cho, Hyunjeong Kim & Eosu Kim Alzheimers Research & Therapy\n\nmedical_services Therapy Indications\n\nInterleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-? and tau pathology in Alzheimer?s disease (2022) Zhi-Bo Wang, Ya-Hui Ma1, Yan Sun1, Lan Tan1, Hui-Fu Wang, Jin-Tai Yu and for the Alzheimer?s Disease Neuroimaging Initiative Journal of Neuroinflammation\n\nmedical_services Therapy Indications\n\nHybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies (2022) Ilya Kister , Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar E. Bacon, Iryna Voloshyna, Annals of Clinical and Translational Neurology\n\nmedical_services Therapy Indications\n\nIL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines (2022) Siri Tahtinen, Ann-Jay Tong, Patricia Himmels, Jaehak Oh, Andres Paler-Martinez, Leesun Kim, Sara Wichner, Yoko Oei, Mark J. McCarron, Emily C. Freund, Zhainib Adel Amir, Cecile C. de la Cruz, Benjamin Haley, Craig Blanchette, Jill M. Schartner, Weilan Ye, Mahesh Yadav, Ugur Sahin, L?lia Delamarre & Ira Mellman Nature Immunology\n\nmedical_services Therapy Indications\n\nUtility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults (2022) Wivine Burny, Caroline Herve, Magalie Caubet, Juan Pablo Yazabal, Arnaud M Didierlaurent Vaccine\n\nmedical_services Therapy Indications\n\nDistinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women (2022) Nardhy Gomez-Lopez, Roberto Romero, Li Tao, Meyer Gershater, Yaozhu Leng, Chengrui Zou, Marcelo Farias-Jofre, Jose Galaz, Derek Miller, Adi L. Tarca, Marcia Arenas-Hernandez, Gaurav Bhatti, Valeria Garcia-Flores, Zhenjie Liu, Robert Para, Tomi Kanninen, Ola Hadaya, Carmen Paredes and Yi Xu Journal of Immunology\n\nmedical_services Therapy Indications\n\nRelationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults (2022) DidacVidal-Pi?eiro, ?ysteinS?rensen, KajBlennow, Elettra Capogna, Nathalie Bodd Halaas, Ane-VictoriaId, Athanasia Monica Mowinckel, Joana Braga Pereira, Leiv Otto Watne, Henrik Zetterberg, Kristine Beate Walhovd, Anders Martin Fjell Neurobiology of Aging\n\nmedical_services Therapy Indications\n\nDefective type I interferon immunity is associated with increasing COVID-19 severity (2022) Nika?a Smith, C?line Poss?m?, Vincent Bondet, Jamie Sugrue, Liam Townsend, Bruno Charbit, Vincent Rouilly, Violaine Saint-Andr?, Tom Dott, Andre Rodriguez Pozo, Nader Yatim, Olivier Schwartz, Minerva Cervantes-Gonzales, Jade Ghosn, Paul Bastard, Jean Laurent Casanova, Tali-Anne Szwebel, Benjamin Terrier, Niall Conlonm, Cliona O?Farrelly, Cl?ona N? Cheallaigh, Nollaig M Bourke, Darragh Duffy Research Square\n\nmedical_services Therapy Indications\n\nAn Exploratory Analysis of Biomarkers of Perihematomal Edema in the CN-105 in Participants with Acute Supratentorial Intracerebral Hemorrhage (CATCH) Trial (2022) Jay B Lusk, Jesse Troy, Nathaniel Nowacki, Peter G Kranz, Maureen Maughan, Daniel T Laskowitz, Michael L James Journal of Stroke and Cerebrovascular Diseases\n\nmedical_services Therapy Indications\n\nChildhood trauma and LPS-stimulated inflammation in adulthood: Results from the Netherlands Study of Depression and Anxiety (2022) Ricki M.de Koning, Erika Kuzminskaite, Christiaan H.Vinkers, Erik J. Giltay, Brenda W.J.H.Penninx Brain, Behavior, and Immunity\n\nmedical_services Therapy Indications\n\nA Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis (2022) Claire Harrison Florian H. Heidel, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Amjad Hayat, Francesco Passamonti, Eibhlin Conneally, Thomas Kindler, Bruno Martino,9 Daniel B. Lipka, Tommaso Stefanelli, Pantelia Roussou,Davide Germano,Jacqueline Ewan, and Vincent Ribrag Hemasphere\n\nmedical_services Therapy Indications\n\nLive enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study (2022) Lars Krogvold, Angelo Genoni, Anna Puggioni, Daniela Campani, Sarah J. Richardson, Christine S. Flaxman, Bj?rn Edwin, Trond Buanes, Knut Dahl-J?rgensen & Antonio Toniolo Diabetologia\n\nmedical_services Therapy Indications\n\nHarnessing the Plasma Proteome to Mirror Current and Predict Future Cardiac Remodeling After Myocardial Infarction (2022) Upendra Chalise, Mediha Becirovic-Agic, Jocelyn R. Rodriguez-Paar, Shelby R. Konfrst, Sharon D. B. de Morais, Catherine S. Johnson, Elizabeth R. Flynn, Michael E. Hall, Daniel R. Anderson, Leah M. Cook, Kristine Y. DeLeon-Pennell & Merry L. Lindsey Journal of Cardiovascular Translational Research\n\nmedical_services Therapy Indications\n\nSex differences in Alzheimer?s disease: plasma MMP-9 and markers of disease severity (2022) Amaryllis A. Tsiknia, Erin E. Sundermann, Emilie T. Reas, Steven D. Edland, James B. Brewer, Douglas Galasko & Sarah J. Banks Alzheimers Research & Therapy\n\nmedical_services Therapy Indications\n\nDistinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation (2022) William Mouton, Anne Conrad, Vincent Alcazer, Mathilde Boccard, Maxime Bodinier, Guy Oriol, Fabien Subtil, Helene Labussiere-Wallet, Sophie Ducastelle-Lepretre, Fiorenza Barraco, Marie Balsat, Gaelle Fossard, Karen Brengel-Pesce, Florence Adler, Sophie Trouillet-Assant Transplantation and Cellular Therapy\n\nmedical_services Therapy Indications\n\nFirst-in-human study of deucravacitinib: A selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2 (2022) Ian M Catlett, Urvi Aras, Lars Hansen, Yali Liu, Di Bei, Ihab G Girgis, Bindu Murthy Clinical Translational Science\n\nmedical_services Therapy Indications\n\nAutologous NK cells propagated and activated ex vivo decrease senescence markers in human PBMCs (2022) Nickolas Chelyapov, Toai T Nguyen, Rafael Gonzalez Biochemistry and Biophysics Reports\n\nmedical_services Therapy Indications\n\nEfficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced of recurrent breast cancer: phase II randomized controlled trial (2022) Hiroji Iwata, Rikiya Nakamura, Norikazu Masuda, Toshinari Yamashita, Yutaka Yamamoto, Kokoro Kobayashi, Junji Tsurutani, Tsutomu Iwasa, Kan Yonemori, Kenji Tamura, Tomoyuki Aruga, Eriko Tokunaga, Koji Kaneko, Min-Jung Lee, Akira Yuno, Azusa Kawabata, Toshihiro Seike, Ayumi Kaneda, Yozo Nishimura, Jane B Trepel, Shigehira Saji Japanese Journal of Clinical Oncology\n\nmedical_services Therapy Indications\n\nAre U-shaped relationships between risk factors and outcomes artifactual? (2022) Reema Shah, Lehana Thabane, Hertzel C. Gerstein Journal of Diabetes\n\nmedical_services Therapy Indications\n\nAdjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response (2022) Adam J. Walker, Mohammadreza Mohebbi, Michael Maes, Michael Berk, Ken Walder, Chiara C. Bortolasci, Zoe SJ. Liu, Chee H. Ng, Melanie M. Ashton, Lesley Berk, Ajeet B. Singh, Gin S. Malhi Olivia M. Dean Brain, Behavior, & Immunity - Health\n\nmedical_services Therapy Indications\n\nInnate immune function during antineoplastic treatment is associated with 12-months survival in non small cell lung cancer (2022) Heidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, Jens Lundgren5,6, Mette P?hl, Seppo W. Langer2, Andreas Kjaer, Sisse Rye Ostrowski and Barbara Malene Fischer Frontiers in Immunology\n\nmedical_services Therapy Indications\n\nTNFRSF1B gene variants and related soluble TNFR2 levels impact reilience in Alzheimers disease (2021) Pillai JA, Bebek G, Khrestian M, Bena J, Bergmann CC, Bush WS, Leverenz JB, Bekris LM Frontiers in Aging Neuroscience\n\nmedical_services Therapy Indications\n\nMuscle damage in systemic sclerosis and CXCL10: The potential therapeutic role of PDE5 inhibition (2021) Corinalesi C, Ross RL, Abignano G, Antinozzi C, Marampon F, di Luigi L, Buch MH, Riccieri V, Lenzi A, Crescioli C, Del Galdo F International Journal of Molecular Sciences\n\nmedical_services Therapy Indications\n\nCharacterization of the pathophysiological determinants of diarrheagenic Escherichia coli infection using a challenge model in healthy adults (2021) van Hoffen E, Mercenier A, Vidal K, Benyacoub J, Schloesser J, Kardinaal A, Lucas-van de Bos E, van Alen I, Rogero I, Duintjer K, Berendts A, Albers R, Kleerebezem M, Bruggencate ST Scientific Reports\n\nmedical_services Therapy Indications\n\nFunctional immune reconstitution early after allogeneic hematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole-blood (2021) Gjaerde LK, Brooks PT, Andersen NS, Friss LS, Kornblit B, Petersen SL, Schjodt I, Nielsen SD, Ostrowski SR, Sengelov H Scandinavaian Journal of Immunology\n\nmedical_services Therapy Indications\n\nDistinct gene regulatory signatures of dominance rank and social bond strength in wild baboons (2021) Anderson JA, Lea AJ, Voyles TN, Akinyi MY, Nyakundi R, Ochola L, Omondi M, Nyundo F, Zhang Y, Campos FA, Alberts SC, Archie EA, Tung J bioRxiv preprint\n\nmedical_services Therapy Indications\n\nAnti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism (2021) Muhlbacher J, Schorgenhofer C, Doberer K, Durr M, Budde K, Eskandary F, Mayer KA, Schranza S, Ely S, Reiter B, Chong E, Adler SH, Jilma B, Bohmig GA Transplant Internatinoal\n\nmedical_services Therapy Indications\n\nVery-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming (2021) Hirschberger S, Straub G, Effinger D, Marstaller X, Ferstl A, Muller MB, Wu T, Hubner M, Rahmel T, Mascolo H, Exner N, Heb J, Kreth FW, Unger K, Kreth S EMBO Molecular Medicine\n\nmedical_services Therapy Indications\n\nHedgehog interacting protein-expressing lung fibroblasts suppress lymphocytic inflammation in mice (2021) Yun JH, Lee CH, Liu S, Kim EY, Xu S, Curtis JL, Pinello L, Bowler RP, Silverman EK, Hersh CP, Zhou X JCI Insight\n\nmedical_services Therapy Indications\n\nValidation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial (2021) Pigeyre M, Hess S, Gomez MF, Asplund O, Groop L, Pare G, Gerstein H Diabetologia\n\nmedical_services Therapy Indications\n\nSerum peptidome: diagnostic window into pathogenic processes following occupational exposure to carbon nanomaterials (2021) Mostovenko E, Dahm MM, Schubauer-Berigan MK, Eye T, Erdely A, Young TL, Campen MJ, Ottens AK Particle and Fibre Toxicology\n\nmedical_services Therapy Indications\n\nInterferon genes are influenced by 17?-estradiol in SLE (2021) Singh RP, Hahn BH, Bischoff DS Frontiers in Immunology\n\nmedical_services Therapy Indications\n\nSoluble amyloid-beta isoforms predict downstream Alzheimers disease pathology (2021) Povala G, Bellaver B, De Bastiani MA, Brum WS, Ferreira PCL, Bieger A, Pascoal TA, Benedet AL, Souza DO, Araujo RM, Zatt B, Rosa-Neto P, Zmmer ER Research Square\n\nmedical_services Therapy Indications\n\nAssessment of advanced glycation end products and receptors and the risk of dementia (2021) Chen J, Mooldijk SS, Licher S, Waqas K, Ikram MK, Uitterlinden AG, Zillikens MC, Ikram MA JAMA Network Open\n\nmedical_services Therapy Indications\n\nFirst-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjects (2021) Yang J, Lickliter JD, Hilson JL, Means GD, Sanderson RJ, Carley K, Tercero A, Manjarrez KL, Wiley JR, Peng SL Clinical and Translational Science\n\nmedical_services Therapy Indications\n\nLY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial (2021) Dowlati A, Jarvey RD, Carvajal RD, Hamid O, Klempner SJ, Wook Kauh JS, Peterson DA, Yu D, CHapman SC, Szpurka AM, Carlsen M, Quinlan T, Wesolowski R Investigational New Drugs\n\nmedical_services Therapy Indications\n\nNovel approaches to develop biomarkers predicting treatment responses to TNF-blockers (2021) Mezghiche I, Yahia-Cherbal H, Rogge L, Bianchi E Expert Review of Clinical Immunology\n\nmedical_services Therapy Indications\n\nMachine learning-based single cell and integrative analysis reveals that baseline mDC predisposition predicts protective Hepatitis B vaccine response (2021) Aevermann B, Shannon CP, Novotny M, Ben-Othman R, Cai B, Zhang Y, Ye JC, Kobor MS, Gladish N, Lee A, Blimke TM, Hancock RE, Llibre A, Duffy D, Koff WC, Sadarangani M, Tebbutt SJ, Kollmann TR, Scheuermann RH medRxiv\n\nmedical_services Therapy Indications\n\nInfluence of cell quality on inflammatory biomarkers in COPD sputum supernatant (2021) Pedersen F, Trinkmann F, Abdo M, Kirsten AM, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O International Journal of Chronic Obstructive Pulmonary Disease\n\nmedical_services Therapy Indications\n\nIdentifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis (2021) Du L, Zhang J, Liu F, Wang H, Guo L, Han J, the Alzheimers Disease Neuroimaging Initiative Medical Image Analysis\n\nmedical_services Therapy Indications\n\nPrimary human dendritic cells and whole-blood based assays to evaluate immuno-modulatory properties of heat-killed commensal bacteria (2021) Norton JE Jr., Kommineni S, Akrivoulis P, Gutierrez DA, Hazuda DJ, Swaminathan G Vaccines\n\nmedical_services Therapy Indications\n\nDifferential response induced by LPS and MPLA in immunocompetent and septic individuals (2021) Vega CA, Karakike E, Bartolo F, Mouton W, Cerrato E, Brengel-Pesce K, Giamarellos-Bourboulis EJ, Mallet F, Trouillet-Assant S Clinical Immunology\n\nmedical_services Therapy Indications\n\nDevelopment of an affordable, sustainable and efficacious plant-based immunomodulatory food ingredient based on bell pepper or carrot RG-I pectic polysaccharides (2021) McKay S, Oranje P, Helin J, Koek JH, Kreijveld E, van den Abbeele P, Phol u, Bothe G, Tzoumaki M, Aparicio-Vergara M Nutrients\n\nmedical_services Therapy Indications\n\nNonclinical development of SRK-181: An anti-latent TGFb1 monoclonal antibody for the treatment of locally advanced or metastatic solid tumors (2021) Welsh BT, Faucette R, Bilic S, Martin CJ, Schurpf T, Chen D, Nicholls S, Lansita J, Kalra A International Journal of Toxicology\n\nmedical_services Therapy Indications\n\nBrentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results (2021) Advani R, Moskowitz AJ, Bartlett NL, Vose J, Ramchandren R, Feldman T, LaCasce AS, Christian B, Ansell SM, Moskowitz CH, Brown L, Zhang C, Taft D, Ansari S, Sacchi M, Ho L, Herrera AF Blood\n\nmedical_services Therapy Indications\n\nNT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia ? A brief report from the ORIGIN trial (2021) Wijkman MO, Claggett BL, Pfeffer MA, Pare G, McQueen M, Hess S, Fu Lee S, Gerstein HC Journal of Diabetes and its Complications\n\nmedical_services Therapy Indications\n\nThe Effect of a natural oral nutritional supplement on the level of intra-articular inflammatory mediators in patients with osteoarthritis of the knee (2021) Sharkey P, Shah Z, Gross M, Meade T, Davidoff S, Shohat N, Parvizi J Journal of Orthopaedic Experience and Innovation\n\nmedical_services Therapy Indications\n\nRegional relationships between CSF VEGF levels and Alzheimers disease brain biomarkers and cognition (2021) Tubi MA, Kothapalli D, Hapenney M, Feingold FW, Mack WJ, King KS, Thompson PM, Braskie MN Neurobiology of Aging\n\nmedical_services Therapy Indications\n\nPretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study (2021) Greil R, Tedeschi A, Moreno C, Anz B, Larratt L, Simkovic M, Gill D, Gribben JG, Flinn IW, Wang Z, Cheung LWK, Nguyen AN, Zhou C, Styles L, Demirkan F Annals of Hematology\n\nmedical_services Therapy Indications\n\nSafety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab teserine in patients with small cell lung cancer (2021) Calvo E, Spira A, de Miguel M, Kondo S, Gazzah A, Millward M, Prenen H, Rottey S, Warburon L, Alanko T, Cassier PA, Yoh K, Italiano A, Moreno V, Peltola K, Seto T, Toyozawa R, Afar DE, Englert S, Komarnitsky P, Lambert S, Parikh A, Vosganian G, Gao B Cancer Treatment and Research Communities\n\nmedical_services Therapy Indications\n\nPreclinical and clinical characterization of the ROR?t inhibitor JNJ-61803534 (2021) Xue X, De Leon-Tabaldo A, Luna-Roman R, Castro G, Albers M, Shoetens F, DePrimo S, Devineni D, Wilde T, Goldberg S, Hoffmann T, Fourie AM, Thurmond RL Scientific Reports\n\nmedical_services Therapy Indications\n\nLigand conjugate structure activity relationships and enhanced endosomal escape with a targeted polymer micelle in non-human primates (2021) Holland RJ, Lam K, Ye X, Martin AD, Wood MC, Palmer L, Fraser D, McClintock K, Majeski S, Jarosz A, Lee ACH, Thi EP, Judge A, Heyes J Molecular Therapy\n\nmedical_services Therapy Indications\n\nThe migration of human follicular dendritic cell-like cell is facilitated by matrix metalloproteinase 3 expression that is mediated through TNFa-ERK1/2-AP1 signaling (2021) Pak HK, Kim YW, Nam B, Lee AN, Roh J, Gil M, Liu C, Chung YS, Park CS Journal of Immunology Research\n\nmedical_services Therapy Indications\n\nFirst-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma (2021) Italiano A, Cassier PA, Lin CC, Alanko T, Peltola KJ, Gazzah A, Shiah HS, Calvo E, Cervantes A, Roda D, Tosi D, Gao B, Millward M, Warburton L, Tanner M, Englert S, Lambert S, Parikh A, Afar DE, Vosganian G, Moreno V Cancer Immunology, Immunotherapy\n\nmedical_services Therapy Indications\n\nProteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid 1-42 (2021) Ekblad LL, Visser PJ, Tijims BM, for the Alzheimers Disease Neuroimaging Initiative Neurobiology of Aging\n\nmedical_services Therapy Indications\n\nA matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis (2021) Alexander Jr LC, McHorse G, Huebner JL, Bay-Jensen AC, Karsdal MA, Kraus VB Arthritis Research & Therapy\n\nmedical_services Therapy Indications\n\nDistinct patterns of blood cytokines beyond a cytokine storm predict mortality in COVID-19 (2021) Herr C, Mang S, Mozafari B, Guenther K, Speer T, seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R Journal of Inflammation Research\n\nmedical_services Therapy Indications\n\nHigh insulin in early childhood is associated with subsequent asthma risk independent of body mass index (2021) Carr TF, Granell R, Stern DA, Guerra S, Wright A, Halonen M, Henderson J, Martinex FD The Journal of Allergy and Clinical Immunology: In Practice\n\nmedical_services Therapy Indications\n\nBiomarker signature in cancer patients with and without venous thromboembolism events: a substudy of CASSINI (2021) Khorana A, Barnard J, Wun T, Vijapurkar U, Damaraju CV, Moore K, Wildgoose P, McCrae K Blood Advances\n\nmedical_services Therapy Indications\n\nRandomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome (2021) Perlin DS, Neil GA, Anderson C, Zafir-Lavie I, Raines S, Ware CF, Wilkins HJ Journal of Clinical Investigation\n\nmedical_services Therapy Indications\n\nCombination of atezolizumab and obinutuzumab in patients with relapsed/refractory follicular lymphoma and diffuse large B-cell lymphome: Results from a phase 1b study (2021) Palomba ML, Till BG, Park SI, Morschhauser F, Cartron G, Marks R, Shivhare M, Hong WJ, Raval A, Change AC, Penuel E, Popplewell LL Clinical Lymphoma Myeloma and Leukemia\n\nmedical_services Therapy Indications\n\nSex-specific differences in peripheral blood leukocyte transcriptional response to LPS are enriched for HLA region and X chromosome genes (2021) Stein MM, Conery M, Magnaye KM, Clay SM, Billstrand C, Nicolae R, Naughton K, Ober C, Thompson EE Scientific Reports\n\nmedical_services Therapy Indications\n\nA phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy (2021) Choueiri TK, Atkins MB, Rose TL, Alter RS, Yawen J, Niland K, Wang Y, Arbeit R, Parasuraman S, Gan L, McDermott DF Investigational New Drugs\n\nmedical_services Therapy Indications\n\nNovel signatures associated with systemic lupus erythematosus clinical response to IFN-a/-? inhibition (2021) Seridi L, Cesaroni M, Orillion A, Schreiter J, Chevrier M, Marciniak S, Migone TS, Stohl W, Chatham WW, Furie RA, Benson J, Jordan J Lupus\n\nmedical_services Therapy Indications\n\nMolecular correlates of response to nivolumab at baseline and on treatment in patients with RCC (2021) Ross-Macdonald P, Walsh AM, Chasalow SD, Ammar R, Papillon-Cavanagh S, Szabo pm, Choueiri TK, Sznol M, Wind-Rotolo M Journal for Immunotherapy for Cancer\n\nmedical_services Therapy Indications\n\nCorrelative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma (2021) Lee CH, Motzer RJ, Glen H, Michaelson MD, Larkin J, Minoshima Y, Kanekiyo M, Ikezawa H, Sachdev P, Dutcus CE, Funashashi Y, Voss MH British Journal of Cancer\n\nmedical_services Therapy Indications\n\nSafety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study (2021) Goepfert PA, Fu B, Chabanon AL, Bonaparte MI, Davis MG, Essink BJ, Frank I, Haney O, Janosczyk H, Keefer MC, koutsoukos M, Kimmel MA, Masotti R, Savarino SJ, Schuerman L, Schwarts H, Sher LD, Smith J, Tavares-Da-Silva F, Gurunathan S, DiazGranados CA, de Bruyn G The Lancet, Infectious Disease\n\nmedical_services Therapy Indications\n\nImproving the power to detect indirect effects in mediation analysis (2021) Kidd J, Lin DY Conrell University\n\nmedical_services Therapy Indications\n\nCSF proteomic Alzheimers disease-predictive subtypes in cognitively intact amyloid negative individuals (2021) Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinex-Lage P, Vandenberghe R, Lleo A, Luis-Molineuvo J, Engelborghs S, Freund-Levi Y, Foelich L, Bertram L, Lovestone S, Streffer J, Vos S, ADNI, Blennow K, Scheltens P, Zetterberg H, Jelle Visser P Proteomes\n\nmedical_services Therapy Indications\n\nNBAS variants are associated with quantitative and qualitative NK and B cell deficiency (2021) Lenz, D, Pahl J, Hauck F, Alameer S, Balasubramanian M, Baric I, Boy N, Church JA, Crushell E, Dick A, Distelmaier F, Gujar J, Indolfi G, Lurz E, Peters B, Schwerd T, Serranti D, Kolker S, Klein C, Hoffmann GF, Prokisch H, Greil J, Cerwenka A, Giese T Staufner C Journal of Clinical Immunology\n\nmedical_services Therapy Indications\n\nPhase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8 (2021) Port A, Shaw JV, Klopp-Schulze L, Bytyqi A, Vetter C, Husey E, Mammasse N, Ona V, Bachmann A, Strugala D, Reh C, Goteti K Pharmacology Researh and Perspective\n\nmedical_services Therapy Indications\n\nAntitumor necrosis factor-like ligand 1A therapy targets tissue inflammation and fibrosis pathways and reduces gut pathobionts in ulcerative colitis (2021) Hassan-Zahraee M, Ye Z, Baniecki ML, Li X, Hyde CL, Zhang J, Raha N, Karlsson F, Quan J, Ziemek D, Neelakantan S, Lepsy C, Allegretti JR, Romatowski J, Scherl EJ, Klopocka M, Danese S, Chandra DE, Schoenbeck U, Vincent MS, Longman R,Hung KE Inflammatory Bowl Diseases\n\nmedical_services Therapy Indications\n\nDiscovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease (2021) Pierson SK, Shenoy S, Oromendia AB, Gorzewski AM, Pai RA, Nabel CS, Ruth JR, parente SAT, Arenas DJ, Guilfoyle M, Reddy MP, Weinblatt M, Shadick N, Bower M, Pria AD, Masaki Y, Katz L, Mezey J, Beineke P, Lee D, Tendler C, Kambayashi T, Fossa A, van Rhee F, Fajgenbaum DC Blood Advances\n\nmedical_services Therapy Indications\n\nAssociation of systemic inflammation with depressive symptoms in individuals with COPD (2021) Strollo HC, Nouraie SM, Hoth KF, Riley CM, Karoleski C, Zhang Y, Hanania NA, Bowler RP, Bon J, Sciurba FC International Journal of Chronic Obstructive Pulmonary Disease\n\nmedical_services Therapy Indications\n\nAssociations of the cerebrospinal fluid hepatocyte growth factor with Alzheimers disease pathology and cognitive function (2021) Zhao LJ, Wang ZT, Ma YH, Zhang W, Dong Q, Yu JT, Tan L, ADNI BMC Neurology\n\nmedical_services Therapy Indications\n\nAssociation of occupational exposures with ex vivo functional immune response in workers handling carbon nanotubes and nanofibers (2020) Schubauer-Berigan MK, Dahm MM, Toennis CA, Sammons DL, Eye T, Kodali V, Zeidler-Erdely PC, Erdely A Nanotoxicology\n\nmedical_services Therapy Indications\n\nACE and Type 2 Diabetes Risk: A Mendelian Randomization Study. (2020) Pigeyre M, Sjaarda J, Chong M, Hess S, Bosch J, Yusuf S, Gerstein H, Pare G Diabetes Care\n\nmedical_services Therapy Indications\n\nCerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying ?-amyloid pathology (2020) Diouf I, Bush AI, Ayton S Neurobiology of Disease\n\nmedical_services Therapy Indications\n\nMeasurement of a Surrogate Biomarker for Arginine Vasopressin Secretion in Association with Physiometric and Molecular Biomarkers of Aging. (2020) Guest PC, Bernstein HB, Dobrowolny H, Borucki K, Westphal S, Steiner J Methods in Molecular Biology\n\nmedical_services Therapy Indications\n\nCharacterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. (2020) Recourt K, van der Aart J, Jacobs G, de Kam M, Drevets W, van Nueten L, Kanhal K, Siebenga P, Zuiker R, Ravenstijn P, Timmers M, van Gerven J, de Boer P Journal of Psychopharmacology\n\nmedical_services Therapy Indications\n\nBiomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-?RI inhibitor galunisertib. (2020) Giannelli G, Santoro A, Kelley RK, Gane E, Paradis V, Cleverly A, Smith C, Estrem ST, Man M, Wang S, Lahn MM, Raymond E, Benhadji KA, Faivre S PLoS One\n\nmedical_services Therapy Indications\n\nFenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study). (2020) Cohen S, Tuckwell K, Katsumoto TR, Zhao R, Galanter J, Lee C,, Rae J, Toth B, Ramamoorthi N, Hackney JA, Berman A, Damjanov N, Fedkov D, Jeka S, Chinn W, Townsend MJ, Morimoto AM, Genovese MC Arthritis& Rheumatology\n\nmedical_services Therapy Indications\n\nSynovial tissue transcriptomes of long-standing rheumatoid arthritis are dominated by activated macrophages that reflect microbial stimulation (2020) Smilijanovic B, Grutzkau A, Sorensen T, Grun JR, Vogl T, Bonin M, Schendel P, Stuhlmuller B, Claussnitzer A, Hermann S, Ohrndorf S, Aupperle K, Backhaus M, Radbruch A, Burmester GR, Haupl T Scientific Reports\n\nmedical_services Therapy Indications\n\nMultiple Biomarker Approach for the Diagnosis and Therapy of Rheumatoid Arthritis (2020) Savvateeva E, Smoldovskaya O, Feyzkhanova G, Rubina A Critical Reviews in Clinical Laboratory Sciences\n\nmedical_services Therapy Indications\n\nProteomic profiling as a diagnotic biomarker for discriminating between bipolar and unipolar depression (2020) Kittel-Schneider S, Hahn T, Haenisch F,McNeill R, Reif A, Bahn S Frontiers in Psychiatry\n\nmedical_services Therapy Indications\n\nFibroblasts from distinct pancreatic pathologies exhibit disease-specific properties (2020) Barrera LN, Evans A, Lane B, Brumskill S, Oldfield FE, Campbell F, Andrews T, Lu Z, Perez-Mancera PA, Liloglou T, Ashworth M, Jalali M, Dawson R, Nunes Q, Phillips PA, Timms JF, Halloran C, Greenhalf W, Neoptolemos JP, Costello E Cancer Research\n\nmedical_services Therapy Indications\n\nPredicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study in the IMI DIRECT cohorts (2020) Atabaki-Pasdar N, Ohlsson M, Vinuela A, Frau F, Pomares-Millan H, Haid M, Jones AG, Thomas EL, Koivula RW, Kurbasic A, Mutie PM, Fitipaldi H, Fernandez J, Dawed AY, Giordano GN, Forgie IM, McDonald TJ, Rutters F, Cederberg H, Chaanova E, Dale M, De Masi F, Thomas CE, Allin KH, Hansen TH, Heggie A, Hong MG, Elders PJM, Kennedy G, Kokkola T, Pedersen HK, Mahajan A, McEvoy D, Pattou F, Raverdy V, Haussler RS, Sharma S, Thomsen HS, Vangipurapu J, Vestergaard H, t Hart LM, Adamski J, Musholt P, Brage S, Brunak S, Dermitzakis E, Frost G, Hansen T, Laakso M, pedersen O, Ridderstrale M, Ruetten H, Hattersley AT, Walker M, Beulens JWJ, Mari A, Schwenk JM, Gupta R, McCarthy MI, Pearson ER, Bell JD, Pavo I, Franks PW PLoS Medicine\n\nmedical_services Therapy Indications\n\nTowards standardization of immune functional assays (2020) Mouton W, Albert-Vega C, Boccard M, Bartolo F, Oriol G, Lopez J, Pachot A, Textoris J, Mallet F, Brengel-Pesce K, Trouillet-Assant S Clinical Immunology\n\nmedical_services Therapy Indications\n\nAn integrative study of five biological clocks in somatic and mental health (2020) Jansen R, Verhoeven J, Han LKM, Aberg KA, van den Oord ECGJ, Milaneschi Y, Penninx BWJH bioRxiv\n\nmedical_services Therapy Indications\n\nPreoperative TruCulture whole blood cytokine response predicts postoperative inflammation in pancreaticoduodenectomy patients - a pilot cohort study (2020) Aasvang EK, Pitter S, Hansen CP, Storkholm JH, Krohn PS, Burgdorf SK, Von Stemann JH, Lundgren JD, Nielsen SD, Kehlet H, Ostrowski SR Scandinavian Journal of Immunology\n\nmedical_services Therapy Indications\n\nInexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimers Disease Neuroimaging (ADNI) database (2020) Beltran JF, Wahba BM, Hose N, Shasha D, Kline RP, ADNI PLoS One\n\nmedical_services Therapy Indications\n\nModel informed dosing regimen and phase I results of the anti-PD-1 antibody budigalimab (ABBV-181) (2020) Powderly J, Spira A, Kondo S, Doi T, Luke JL, Rasco D, Gao B, Tanner M, Cassier PA, Gazzah A, Italiano A, Tosi D, Afar DE, Parikh A, Engelhardt B, Englert S, Lambert SL, Kasichayanula S, Mensing S, Menon R, Vosganian G, Tolcher A Clinical and Translational Science\n\nmedical_services Therapy Indications\n\nInvestigating data-driven biological subtypes of sychiatric disorders using specification-curve analysis (2020) Beijers L, van Loo HM, Romeijn JW, Lamers F, Schoevers RA, Wardenaar KJ Psychological Medicine\n\nmedical_services Therapy Indications\n\nExploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab - a study protocol (2020) Takeshi N, Kenji I, Daisuke O, Satoshi N, Risa TM, Koji M, Susumu I, Hidehisa S, Yudai K, Riichiro A, Mamitaro O, Koji K, Tatsuro O, Tomomitsu M, Yozo I, Akihiko a, Hiroshi K, Keiji T, Hiroshi M, Tatsuyoshi K, Takuya T, Masashi A, Emi N, Akimchi M, Kyoko t, Yukinobu N, Koji S, Chicharu T, YOko K, Rai F, Sakae K, Eishin M, Akio T, Mchihiro H, Natsuko A, Shigetoshi S, Haruna M, Yutaka H, Motoi T, Hiroyuki M, Norito K, Masutaka F Medicine\n\nmedical_services Therapy Indications\n\nTranscutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial (2020) Aranow C, Atish-Fregoso Y, Lesser M, Mackay M, Anderson E, Chavan S, Zanos TP, Datta-Chaundhuri T, Bouton C, Tracey KJ, Diamond B Annals of the rheumatic diseases\n\nmedical_services Therapy Indications\n\nBasal forebrain degeneration and cortisol as biomarkers mediating Alzheimers disease pathology: a machine learning approach (2020) Nakirikanti AS Research Thesis\n\nmedical_services Therapy Indications\n\nThe utility of novel urinary biomarkers in mice for drug development studies (2020) Adedeji AO, Gu YZ, Pourmohamad T, Kanerva J, Chen Y, Atabakhsh E, Tackett MR, Chen F, Bhatt B, Gury T, Dorchies O, Sonee M, Morgan M, Burkey J, Gautier JC, McDuffie JE International Journal of Toxicology\n\nmedical_services Therapy Indications\n\nCharacterization of LY2775240, a selective phosphodiesterase-4 inhibitor, in nonclinical models and in healthy subjects (2020) Patel DR, Urva S, Ho S, Buckman CJ, Ma Y, Lim J, Sissons SE, Zuniga MS, Philips D, Cox K, Dairaghi D Clinical and Translational Science\n\nmedical_services Therapy Indications\n\nComparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes. (2020) Colombo M, McGurnaghan SJ, Blackbourn LAK, Dalton RN, Dunger D, Bell S, Petrie JR, Green F, MacRury S, McKnight JA, Chalmers J, Collier A, McKeigue PM, Colhoun HM, Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Investigators Diabetologia\n\nmedical_services Therapy Indications\n\nApplication of the TruCulture? whole blood stimulation system for immune response profiling in cattle (2020) OBrien MB, McLoughlin RM, Meade KG Veterinary Immunology and Immunopathology\n\nmedical_services Therapy Indications\n\nUnderlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia (2020) Narayanan P, Curtis BR, Shen L, Schneider E, Tami JA, Paz S, Burel SA, Tai LJ, Machemer T, Kwoh TJ, Xia S, Shattil SJ, Witztum JL, Engelhardt JA, Henry SP, Monia BP, Hughes SG Nucleic Acid Therapeutics\n\nmedical_services Therapy Indications\n\nPhase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma. (2020) Wick A, Desjardins A, Suarez C, Forsyth P, Gueorguieva I, Burkholder T, Cleverly AL, Estrem ST, Wang S, Lahn MM, Guba SC, Capper D, Rodon J Investigational New Drugs\n\nmedical_services Therapy Indications\n\nDegree of Genetic Liability for Alzheimer?s Disease Associated with Specific Proteomic Profiles in Cerebrospinal Fluid (2020) Reus LM, Stringer S, Posthuma D, Teunissen CE, Scheltens P, Pijnenburg YAL, Visser PJ, Tijms BM, for the Alzheimers Disease Neuroimaging Neurology of Aging\n\nmedical_services Therapy Indications\n\nProteomics as a reliable approach for discovery of blood-based Alzheimers disease biomarkers: a systematic review and meta-analysis. (2020) Rehiman SH, Lim SM, Neoh CF, Majeed ABA, Chin AV, Tan MP, Kamaruzzaman SB, Ramasamy K Ageing Reserch Reviews\n\nmedical_services Therapy Indications\n\nHigh cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study (2020) Nenna R, Zhai J, Packard SE, Spangenberg A, Sherrill DL, Martinez FD, Halonen M, Guerra S ERJ Open Research\n\nmedical_services Therapy Indications\n\nAPOE e4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer?s disease (2020) Konijnenberg E, Tijms BM, Gobom J, Dobricic V, Bos I, Vos S, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleo A, Frolich L, Lovestone S, Streffer J, Bertram L, Blennow K, Teunissen CE, Veerhuis R, Smit AB, Scheltens P, Zetterberg H, Visser PJ Alzheimers Research & Therapy\n\nmedical_services Therapy Indications\n\nA comprehensive systematic review of CSF proteins and peptides that define Alzheimer?s disease (2020) Pedrero-Prieto CM, Garcia-Carpintero S, Frontinan-Rubio J,Llanos-Gonzalez E, Aguilera Garcia C, Alcain FJ, Lindberg I, Duran-Prado M, Peinado J, Rabanal-Ruiz Y Clinical Proteomics\n\nmedical_services Therapy Indications\n\nSystemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation (2020) Jorgensen SE, Christiansen M, Host C, Glerup M, Mahler B, Lausten MM, Gad HH, Hartmann R, Herlin T, Mogensen TH Rheumatology\n\nmedical_services Therapy Indications\n\nSerum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition (2020) Laino AS, Woods D, Vassallo M, Qian X, Tang H, Wind-Rotolo M, Weber J Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nElevated plasma cortisol associated with larger ventricles and smaller hippocampal volumes - a study in 2 independent elderly cohorts (2020) Rajagopalan P, Nho K, Risacher SL, Jahanshad N, Boyle CP, Saykin AJ, Thompson PM bioRxiv\n\nmedical_services Therapy Indications\n\nThe effects of rare SERPINA1 variants on lung function and emphysema in SPIROMICS (2020) Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski P, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Douper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R III, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER American Journal of Respiratory and Critical Care Medicine\n\nmedical_services Therapy Indications\n\nA phase I study of ASTX660, an antagonist of inhibitors of apoptosis proteins, in adults with advanced cancers or lymphoma (2020) Mita MM, LoRusso PM, Papadopoulos KP, Gordon MS, Mita AC, Ferraldeschi R, Keer H, Oganesian A, Su XY, Jueliger S, Tolcher AW Clinical Cancer Research\n\nmedical_services Therapy Indications\n\nResults of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium bacillus calmette guerin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy (2020) Rentsch CA, Bosshard P, Mayor G, Rieken M, Puschel H, Wirth G, Cathomas R, Parzmair GP, Grode L, Eisele B, Sharma H, Gupta M, Gairola S, Shaligram U, Goldenberger D, Spertini F, Audran R, Enoui M, Beradi S, Hayoz S, Wicki A Oncoimmunology\n\nmedical_services Therapy Indications\n\nPlasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration (2020) Lashkari K, Teague GC, Beattie U, Betts J,Kumar S, McLaughlin MM, Lopez FJ PLOS One\n\nmedical_services Therapy Indications\n\nReduced chronic toxicity and carcinogenicity in A/J mice in response to life-time exposure to aerosol from a heated tobacco product compared with cigarette smoke (2020) Wong ET, Luettch K, Krishan S, Wong SK, Lim WT, Yeo D, Buttner A, Leroy P, Vuillaume G, Boue S, Hoeng J, Vansheeuwijck P, Peitsch M Toxicological Sciences\n\nmedical_services Therapy Indications\n\nRapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes (2020) Adams SF, Grimm AJ, Chiang CLL, Mookerjee A, Flies D, Jean S, McCann GA, Michaux J, Pak H, Huber F, Neal C, Dangaj D, Bassani-Sternberg M, Rusakiewicz S, Facciabene A, Coukos G, Gimotty PA, Kandalaft LE Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nPreclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,30dioxygenase 2, in patients with advanced solid tumors (2020) Naing A, Eder JP, Piha-Paul SA, Gimmi C, Hussey E, Zhang S, Hildebrand V, Hosagrahara V, Habermehl C, Moisan J, Papadopoulos KP Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nGenetics meets proteomics: perspectives for large population-based studies (2020) Suhre K, McCarthy MI, Schwenk JM Nature Reviews Genetics\n\nmedical_services Therapy Indications\n\nModulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus (2020) Casey KA, Smith MA, Sinibaldi D, Seto NL, Playford MP, Wang X, Carlucci PM, Wang L, Illei G, Yu B, Wang S, Remaley AT, Mehta NH, Kaplan MJ, White WI Arthritis Rheumatology\n\nmedical_services Therapy Indications\n\nInflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimers disease (2020) Pillai JA, Bena J, Bebek Gurkan, Bekris LM, Bonner-Jackson A, Kou L, Pai A, Sorensen L, Neilsen M, Rao SM, Chance M, Lamb BT, Leverenz JB, Alzheimers Disease Neuroimaging Initiative Annals of Clinical and Translational Neurology\n\nmedical_services Therapy Indications\n\nHepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk (2020) Morris JS, Hassan MM, Zohner YE, Wang Z, Xiao L, Rashid A, Haque A, Abdel-Wahab R, Mohamed YA, Ballard KL, Wolff RA, George B, Li L, Allen G, Weylandt M, Li D, Wang W, Raghav K, Yao J, Amin HM, Kaseb AO Heptology\n\nmedical_services Therapy Indications\n\nFirst-in-human, single- and multiple-ascending dose studies in healthy subjects to assess pharmacokinetics, pharmacodynamics, and safety/tolerability of iberdomide, a novel cereblon E3 ligase modulator (2020) Ye Y, Gaudy A, Schafer P, Thomas M, Weiss D, Chen N, Liu L, Xue Y, Carayannopoulos L, Palmisano M Clinical Pharmacology in Drug Development\n\nmedical_services Therapy Indications\n\nDeciphering heterogeneity of septic shock patients using immune functional assays: a proof of concept study (2020) Albert Vega C, Oriol G, Bartolo F, Lopez J, Pachot A, Rimmele T, Venet F, Leray V, Monneret G, Delwarde B, Brengel-Pesce K, Textoris J, Mallet F, Trouillet-Assant S Scientific Reports\n\nmedical_services Therapy Indications\n\nGenomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals (2020) Fokersen L, Gustafsson S, Qang Q, Hansen DH, Hedman AK, Schork A, Page K, Zhernakova DV, Wu Y, Peteres J, Eriksson N, Bergen SE, Boutin TS, Bretherick AD, Entroth S, Kalnapenkis A, Gadin JR, Suur BE, Chen Y, Matic L, Gale JD, Lee J, Zhang W, Quazi A, Ala-Korpela M, Choi SH, Claringbould A, Danesh J, Smith GD, de Masi F, Elmstahl S, Engstrom G, Fauman E, Fernandez C, Franke L, Franks PW, Giedraitis V, Haley C, Hamsten A, Ingason A, Johansson A, Joshi PK, Lind L, Lindgren CM, Lubitz S, Palmer T, Macdonald-Dunlop E, Magnusson M, Melander O, Michaelsson K, Morris AP, Magi R, Nagle MW, Nilsson PM, Nilsson J, Orho-Melander M, Polasek O, Prins B, Palsson E, Qi T, Sjogren M, Sundstrom J, Surendran P, Vosa U, Werge T, Wernersson R, Westra HJ, Yang J, Zhernakova A, Arnlov J, Fu J, Smith JG, Esko T, Hayward C, Gyllensten U, Landen M, Siegbahn A, Wilson JF, Wallentin L, Butterworth AS, Homes MV, Ingelsson E, Malarstig A Nature Metabolism\n\nmedical_services Therapy Indications\n\nLeft and right atrial biomarker analysis in atrial fibrillation (2020) Goldberger JJ, Green D, Ringwala S, Andrei AC, Xu Y, Passman R JACC Clinical Electrophysiology\n\nmedical_services Therapy Indications\n\nIdentifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort (2020) Bauer Y, de Bernard S, Hickey P, Ballard K, Cruz J, Cornelisse P, Chadha-Boreham H, Distler O, Rosenberg D, Doelberg M, Roux S, Nayler O, Lawrie A European Respiratory Journal\n\nmedical_services Therapy Indications\n\nNeuroinflammation trajectories precede cognitive impairment after experimental meningitis-evidence from an in vivo PET study. (2020) Giridharan VV, Collodel A, Generoso JS, Scaini G, Wassather R, Selvaraj S, Hasbun R, Dal-Pizzol F, Petronilho F, Barichello T Journal of Neuroinflammation\n\nmedical_services Therapy Indications\n\nFilgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials. (2020) Tarrant JM, Galien R, Li W, Goyal L, Pan Y, Hawtin R, Zhang W, Van der Aa A, Taylor PC Rheumatol Ther\n\nmedical_services Therapy Indications\n\nNeutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis. (2020) Herster F, Bittner Z, Archer NK, Dickhofer S, Eisel D, Eigenbrod T, Knorpp T, Schneiderhan-Marra N, Loffler MW, Kalbacher H, Vierbuchen T, Heine H, Miller LS, Hartl D, Freund L, Schakel K, Heister M, Ghoreschi K, Weber ANR Nature Communications\n\nmedical_services Therapy Indications\n\nNasal Microbiota Modifies the Effects of Particulate Air Pollution on Plasma Extracellular Vesicles. (2020) Mariana J, Favero C, Carungno M, Pergoli L, Ferrari L, Bonzini M, Cattaneo A, Pesatori AC, Bollati V International Journal of Environmental Research and Public Health\n\nmedical_services Therapy Indications\n\nDynamic Aspects of Associations in Coronary Artery Disease: From Intracoronary Imaging to Blood Biomarkers (2020) Buljubasic, N. Erasmus University Rotterdam\n\nmedical_services Therapy Indications\n\nInfluence of Genetic Ancestry on Human Serum Proteome (2020) Sjaarda J, Gerstein HC, Kutalik Z, Mohammadi-Shemirani P, Pigeyre M, Hess S, Pare G The American Journal of Human Genetics\n\nmedical_services Therapy Indications\n\nUrelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma (2020) Timmerman J, Herbaux C, Ribrag V, Zelenetz AD, Houot R, Neelapu SS, Logan T, Lossos IS, Urba W, Salles G, Ramchandren R, Jacobson C, Godwin J, Carpio C, Lathers D, Liu Y, Neely J, Suryawanshi S, Koguchi Y, Levy R American Journal of Hematology\n\nmedical_services Therapy Indications\n\nMolecular Epidemiology of Inflammation Link with Type 2 Diabetes and Coronary Heart Disease (2020) Ligthart S Erasmus University Rotterdam\n\nmedical_services Therapy Indications\n\nQuantitative Assays of Plasma Apolipoproteins. (2020) Poljak A, Duncan MW, Jayasena T, Sachdev PS Methods of Molecular Biology\n\nmedical_services Therapy Indications\n\nElevated serum interlukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors (2020) Schalper KA, Carleton M, Zhou M, Chen T, Feng Y, Huang SP, Walsh AM, Baxi V, Pandya D, Baradet T, Locke D, Wu Q, Reilly TP, Phillips P, Nagineni V, Gianino N, Gu J, Zhao H, Perez-Gracia JL, Snmamed MF, Melero I Nature Medicine\n\nmedical_services Therapy Indications\n\nSystematic investigation of polyurethane biomaterial surface roughness on human immune responses in vitro (2020) Segan S, Jakobi M, Khokhani P, Klimosch S, Billing F, Schneider M, Martin D, Metzger U, Biesemeier A, Xiong X, Mukherjee A, Steuer H BioMed Research International\n\nmedical_services Therapy Indications\n\nInnate Immune Stimulation of Whole Blood Reveals IFN-1 Hyper-Responsiveness in Type 1 Diabetes (2020) Rodrigues KB, Dufort MJ, Llibre A, Speake C, Jubayer Rahman M, Bondet V, Quiel J, Linsley PS, Greenbaum CJ, Duffy D, Tarbell KV Diabetologia\n\nmedical_services Therapy Indications\n\nSerum biomarkers that predict lean mass loss over bed rest in older adults: An exploratory study (2020) Gawel SH, Davis GJ, Luo M, Deutz NEP, Wolfe RR, Pereira SL Clinica Chimica Acta\n\nmedical_services Therapy Indications\n\nComparison of host immune responses to LPS in human using an immune profiling panel, in vivo endotaxemia versus ex vivo stimulation (2020) Tawfik DM, Lankelma JM, Vachot L, Cerrato E, Pachot A, Wiersinga WJ, Textoris J Scientific Reports\n\nmedical_services Therapy Indications\n\nInhibition of cytokine signaling by ruxolitinib and implactions for COVID-19 treatment (2020) Yeleswaram S, Smith P, Burn T, Covington M, Juvekar A, Li Y, Squier P, Langmuir P Clinical Immunology\n\nmedical_services Therapy Indications\n\nUsing the circulating proteome to assess type I interferon activity in systemic lupus erythematosus (2020) Smith MA, Chiang CC, Zerrouki K, Rahman S, White W, Streicher K, Rees WA, Schiffenbauer A, Rider LG, Miller FW, Manna Z, Hasni S, Kaplan M, Siegel R, Sinibaldi D, Sanjuan MA, Casey KA Scientific Reports\n\nmedical_services Therapy Indications\n\nEosinophils regulate adipose tissue inflammation and sustain physical and immunological fitnes in old age (2020) Brigger D, Riether C, van Brummelen R, Mosher KI, Shiu A, Ding Z, Zbaren N, Gasser P, Guntern P, Yousef H, Castellano JM, Storni F, Graff-Radford N, Britschgi M, Grandgirard D, Hinterbrandner M, Siegrist M, Moullan N, Hofstetter W, Leib SL, Villiger PM, Auwerx J, Villeda SA, Wyss-Coray T, Noti M, Eggel A Nature Metabolism\n\nmedical_services Therapy Indications\n\nImpact of carbohydrate-reduced nutrition in septic patients on ICU: study protocol for a prospective randomised controlled trial (2020) Rahmel T, Hubner M, Koos B, Wolf A, Willemsen KM, Straub G, Effinger D, Adamzik M, Kreth S BMJ Open\n\nmedical_services Therapy Indications\n\nBasal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression (2020) van Eeden WA, van Hemert AM, Carlier IVE, Penninx BWJH, Fried EI, Schoevers R, Giltay EJ Translational Psychiatry\n\nmedical_services Therapy Indications\n\nImmune transriptome of cells infected with enterovirus strains obtained from cases of type 1 diabetes (2020) Poma AM, Genoni A, Broccolo F, Denaro M, Pugliese A, Basolo F, Toniolo A Microorganisms\n\nmedical_services Therapy Indications\n\nSafety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study (2020) Genovese MC, Gaylis NB, Sikes D, Kivitz A, Horowitz DL, Peterfy C, Glass EV, Levine YA, Chernoff D The Lancet Rheumatology\n\nmedical_services Therapy Indications\n\nMolecular biomarkers of anti-TNF response in patients with rheumatoid arthritis (2020) Yoosuf N, Maciejewski M, Ziemek D, Jelinsky S, Folkersen, Muller M, Sahlstrom P, Vivar N, Catrina A, Berg L, Klareskog L, Padyukov L, Brynedal B Arthritis Research & Therapy\n\nmedical_services Therapy Indications\n\nImmune profiling enables stratification of patients with active TB disease or M. tuberculosis infection (2020) Duffy D, Nemes E, Llibre A, Rouilly V, Musvosvi M, Smith N, Filander E, Africa H, Mabwe S, Jaxa L, Charbit B, Mulenga H, the Milieu Interieur Consortium, Tameris M, Walzl G, Malherbe S, Thomas S, Hatherill M, Bilek N, Scriba TJ, Albert ML Clinical Infectious Diseases\n\nmedical_services Therapy Indications\n\nMethamphetamine increases the proportion of SIV-infected microglia/macrophases, alters metabolic pathways, and elevates cell death pathways: a single-cell analysis (2020) Niu M, Morsey B, Lamberty BG, Emanuel K, Yu F, Leon-Rivera R, Berman JW, Gaskill PJ, Matt SM, Ciborowski PS, Fox HS Viruses\n\nmedical_services Therapy Indications\n\nEfficacy and safety of abatacept in active primary Sj?grens syndrome: results of a phase III, randomised, placebo-controlled trial (2020) Baer AN, Gottenberg JE, St Clair EW, Sumida T, Takeuchi T, Seror R, Foulks G, Nys M, Mukherjee S, Wong R, Ray N, Boothsma H Annals of the Rheumatic Disease\n\nmedical_services Therapy Indications\n\nImmune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo (2020) Menegatti S, Guillemot V, Latis E, Yahia-Cherbal H, Mittermuller D, Rouilly V, Mascia E, Rosine N, Koturan S, Millot G, Leloup C, Duffy D, Gleizes A, Hacein-Bey-Abina S, Milieu interieur Consortium, Sellam J, Berenbaum F, Miceli C, Dougados M, Bianchi E, Rogge L Ann Rheum Dis\n\nmedical_services Therapy Indications\n\nSoluble receptor for advanced glycation end products (sRAGE) as a biomarker for COPD (2020) Pratte KA, Curtis JL, Kechris K, Couper D, Cho MH, Silverman EK, DeMeo DL, Sciurba FC, Zhang Y, Ortega VE, ONeal W, Gillenwater LA, Lynch DA, Newell Jr JD, Comellas AP, Castaldi PJ, Miller B, Pouwels SD, ten Hacken NHT, Bischoff R, Klont F, Woodruff P, Paine R, Barr RG, Hoidal J, Doerschuk CM, Charbonnier JP, Sung R, Locantore N, Yonchuk J, Tal-Singer R, Jacobson S, Merrill D, Bowler RP Research Square\n\nmedical_services Therapy Indications\n\nSystems biology methods applied to blood and tissue for comprehensive analysis of immune response to hepatitis B vaccine in adults (2020) Ben-Othman R, Cai B, Liu AC, Varankovich N, He D, Blimkie TM, Lee AH, Gill EE, Novotny M, Aevermann B, Drissler s, Shannon CP, McCann S, Marty K, Bjornson G, Edgar RD, Lin DTS, Gladish N, MacIsaac J, Amenyogbe N, Chan Q, Libre A, Collin J, Landais, E, Le K, Reiss SM, Koff WC, Havenar-Daughton C, Heran M, Sangha B, Walt D, Krajden M, Crotty S, Sok D, Briney B, Burton DR, Duffy D, Foster LJ, Mohn WW, Kobor MS, Tebbutt SJ, Brinkman RR, Scheuermann RH, Hancock REW, Kollmann TR, Sadarangani M Frontiers in Immunology\n\nmedical_services Therapy Indications\n\nA new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. (2019) Rammensee HG, Wiesmuller KH, Chandran PA, Zelba H, Rusch E, Gouttefangeas C, Kowalewski DJ, Di Marco M, Haen SP, Walz JS, Gloria YC, Bodder J, Schertel JM, Tunger A, Muller L, Kiebler M, Wehner R, Schmitz M, Jakobi M, Schneiderhan-Marra N, Klein R, Laske K, Artzner K, Backert L, Schuster H, Schwenck J, Weber ANR, Pichler BJ, Kneilling M, la Fougere C, Forchhammer S, Metzler G, Bauer J, Weide B, Schippert W, Stevanovic S, Loffler MW Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nMetabolomic analyses reveal lipid abnormalities and hepatic dysfunction in non-human primate model for Yersinia pestis (2019) Gautam A, Muhie S, Cakraborty N, Hoke A, Donohue D, Miller SA, Hammamieh R, Jett M Metabolomics\n\nmedical_services Therapy Indications\n\nApplying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses. (2019) Kline RA, Wishart TM, Mills K, Heywood WE BBA - Molecular Basis of Disease\n\nmedical_services Therapy Indications\n\nIdentification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk (2019) Pigeyre M, Sjaarda J, Mao S, Chong M, Hess S, Yusuf S, Gerstein H, Pare G Diabetes Care\n\nmedical_services Therapy Indications\n\nT cell phenotypes are associated with serum IgE levels in Amish and Hutterite children (2019) Hrusch CL, Stein MM, Gozdz J, Holbreich M, Von Mutius E, Vercelli D, Ober C, Sperling AI Journal of Allergy and Clinical Immunology\n\nmedical_services Therapy Indications\n\nType I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus (2019) Thanarajasingam U, Muppirala AN, Jensen MA, Ghodke-Puranik Y, Dorschner JM, Vsetecka DM, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold TB ACR Open Rheumatology\n\nmedical_services Therapy Indications\n\nMajor depression and enhanced molecular senescence abnormalities in young and middle-aged adults. (2019) Diniz BS, Reynolds Iii CF, Sibille E, Bot M, Penninx BWJH Translational Psychiatry\n\nmedical_services Therapy Indications\n\nTherapy with 2O methly phosphorothioate antisense oligonucleotides causes reversible proteinuria by inhibiting renal protien reabsorption (2019) Janssen MJ, Nieskens TTG, Steevels TAM, Caetano-Pinto P, den Braanker D, Mulder M, Ponstein Y, Jones S, Masereeuw R, den Besten C, Wilmber MJ Molecular Therapy Nucleic Acids\n\nmedical_services Therapy Indications\n\nApremilast Mechanism of Efficacy in Systemic-Naive Patients With Moderate Plaque Psoriasis: Pharmacodynamic Results From the UNVEIL Study (2019) Strober B, Alikhan A, Lockshin B, Shi R, Cirulli J, Schafer P Journal of Dermatological Science\n\nmedical_services Therapy Indications\n\nDiscovery and validation of a biomarker model (preserve) predictive of renal outcomes after liver transplantation (2019) Levitsky J, Asrani SK, Klintmalm G, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Jennings LW, Brown M, Armstrong B, Abecassis M Hepatology\n\nmedical_services Therapy Indications\n\nExtracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation (2019) Bornstein SR, Voit-Bak K, Rosenthal P, Tselmin S, Julius U, Schatz U, Boehm BO, Thuret S, Kempermann G, Reichmann H, Chrousos GP, Licinio J, Wong ML, Schally AV, Straube R Molecular Psychiatry\n\nmedical_services Therapy Indications\n\nA rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough. (2019) Ahmad R, Xie L, Pyle M, Suarez MF, Broger T, Steinberg D, Ame SM, Lucero MG, Szucs MJ, MacMullan M, Berven FS, Dutta A, Sanvictores DM, Tallo VL, Bencher R, Eisinger DP, Dhingra U, Deb S, Ali SM, Mehta S, Fawzi WW, Riley ID, Sazawal S, Premji Z, Black R, Murray CJL, Rodriguez B, Carr SA, Walt DR, Gillette MA Science Translational Medicine\n\nmedical_services Therapy Indications\n\nTumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab. (2019) Molinero L, Li Y, Chang CW, Maund S, Berg M, Harrison J, Fasso M, OHear C, Hedge P, Emens LA Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nSpebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study. (2019) Schafer PH, Kivitz AJ, Ma J, Korish S, Sutherland D, Li L, Azaryan A, Kosek J, Adams M, Capone L, Hur EM, Hough DR, Ringheim GE Rheumatology and Therapy\n\nmedical_services Therapy Indications\n\nA Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma. (2019) Wang R, Shao X, Zheng J, Saci A, Qian X, Pak I, Roy A, Bello A, Rizzo JI, Hosein F, Moss RA, Wind-Rotolo M, Feng Y Clinical Pharmacology and Therapeutics\n\nmedical_services Therapy Indications\n\nDevelopment of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma. (2019) Wang R, Zheng J, Shao X, Ishii Y, Roy A, Bello A, Lee R, Zhang J, Wind-Rotolo M, Feny Y Journal for ImmunoTherapy of Cancer\n\nmedical_services Therapy Indications\n\nAdjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis (2019) Curtis JR, Flake DD 2nd, Weinblatt ME, Shadick NA, Ostergaard M, Hetland ML, Brahe CH, Hwang YG, Furst DE, Strand V, Etzel CJ, Pappas DA, Wang X, Hwang CC, Sasso EH, Gutin A, Hitraya E, Lanchbury JS Rheumatology\n\nmedical_services Therapy Indications\n\nCortisol associated with hypometabolism across the Alzheimers disease (2019) Wirth M, Huijbers W, Lange C bioRxiv\n\nmedical_services Therapy Indications\n\nModulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases (2019) Sridhar S, Liu H, Damera G, Newbold P Respiratory Research\n\nmedical_services Therapy Indications\n\nSocial history and exposure to pathogen signals modulate social status effects on gene regulation in rhesus macaques (2019) Sanz J, Maurizio PL, Snyder-Mackler N, Simons ND, Voyles T, Kohn J, Michopoulos V, Wilson M, Tung J, Barreiro LB bioRxiv\n\nmedical_services Therapy Indications\n\nInflammatory parameters associated with systemic reactogenicity following vaccinatino with adjuvanted hepatitis B vaccines in humans (2019) Burny W, Marchant A, Herve C, Callegaro A, Caubet M, Fissette L, Gheyle L, Legrand C, Ndour C, Tavares Da Silva F, van der Most R, Willems F, Didierlaurent AM, Yarzabal J, ECR-008 study group Vaccine\n\nmedical_services Therapy Indications\n\nCitrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak (2019) Gramaglia I, Velez J, Chang YS, Caparros-Wanderley W, Combes V, Grau G, Stins MF, van der Heyde HC PLoS One\n\nmedical_services Therapy Indications\n\nA blood-based signature of cerebrospinal fluid A?1-42 status (2019) Goudey B, Fung BJ, Schieber C, Faux NG, Alzheimers Disease Metabolomics Consortium, Alzheimers Disease Neuroimaging Initiative Scientific Reports\n\nmedical_services Therapy Indications\n\nExternal Validation of a Pre-Transplant Biomarker Model (REVERSE) Predictive of Renal Recovery after Liver Transplantation (2019) Levitsky J, Asrani SK, Abecassis M, Ruiz R, Jennings LW, Klintmalm G Hepatology\n\nmedical_services Therapy Indications\n\nBiomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management (2019) Savvateeva EN, Rubina AY, Gryadunov DA BioMed Research International\n\nmedical_services Therapy Indications\n\nKey inflammatory pathway activations in the MCI stage of Alzheimers disease (2019) Pillai JA, Maxwell S, Bena J, Bekris LM, Rao SM, Chance M, Lamb BT, Leverenz JB Annals of Clinical and Translational Neurology\n\nmedical_services Therapy Indications\n\nIL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. (2019) Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO , Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC The Journal of Clinical Investigation\n\nmedical_services Therapy Indications\n\nThe systemic exercise-released chemokine lymphotactin/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation. (2019) Leiter O, Bernas SN, Seidemann S, Overall RW, Horenburg C, Kowal S, Kempermann G, Walker TL Scientific Reports\n\nmedical_services Therapy Indications\n\nTargeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis. (2019) Lai JH, Luo SF, Ho LJ Cells\n\nmedical_services Therapy Indications\n\nPlasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome. (2019) Hanudel MR, Zinter MS, Chen L, Gala K, Lim M, Guglielmo M, Deshmukh T, Vangala S, Matthay M, Sapru A PLoS One\n\nmedical_services Therapy Indications\n\nPlasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimers disease (2019) Wu W, Su BJ, Shen XN, Bi YL, Tan CC, Li JQ, Dong Q, Tan L, Alzheimers Disease Neuroimaging Initiative, Yu JT Cognitive Neuroscience\n\nmedical_services Therapy Indications\n\nA clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography (2019) Nasrien E. Ibrahim, Cian P. McCarthy, Shreya Shrestha, Hanna K. Gaggin, Renata Mukai, Craig A. Magaret, Rhonda F. Rhyne and James L. Januzzi, Jr Clinical Cardiology\n\nmedical_services Therapy Indications\n\nBiomarker panels associated with progression of renal disease in type 1 diabetes. (2019) Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM Diabetologia\n\nmedical_services Therapy Indications\n\nImmune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. (2019) Hotchkiss RS, Colston E, Yende S, Crouser ED, Martin GS, Alberson T, Bartz RR, Brakenridge SC, Delano MJ, Park PK, Donnino MW, Tidswell M, Mayr FB, Angus DC, Coopersmith CM, Moldawer LL, Catlett IM, Girgis IG, Ye J, Grasela DM Intensive Care Med\n\nmedical_services Therapy Indications\n\nSLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus (2019) Smith MA, Henault J, Karnell JL, Parker ML, Riggs JM, Sinibaldi D, Taylor DK, Ettinger R, Grant EP, Sanjuan MA, Kolbeck R, Petri MA, Casey KA Scientific Reports\n\nmedical_services Therapy Indications\n\nFunctional immune monitoring in severely injured patients - a pilot study. (2019) Halbgebauer R, Kllermann S, Schafer F, Weckbach S, Weiss M, Barth E, Bracht H, Kalbitz M, Gebhard F, Huber-Lang MS, Perl M Scandinavian Journal of Immunology\n\nmedical_services Therapy Indications\n\nLarge-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic Effects (2019) Medvedeva IV, Stokes ME, Eisinger D, LaBrie ST, Ai J, Trotter MWB, Schafer P, Yang R Scientific Reports\n\nmedical_services Therapy Indications\n\nPhase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors (2019) Piha-Paul SA, Hann CL, French CA, Cousin S, Brana I, Cassier PA, Moreno V, de Bono JS, Duckworth Harward S, Ferron-Brady G, Barbash O, Wyce A, Wu Y, Horner T, Annan M, Parr NJ, Prinjha RK, Carpenter CL, Hilton J, Hong DS, Hass NB, Markowski MC, Dhar A, ODwyer PJ, Shapiro GI JNCI Cancer Spectrum\n\nmedical_services Therapy Indications\n\nMethionine restriction delays aging-related urogenital diseases in male Fischer 344 rats. (2019) Komninou D, Malloy VL, Zimmerman JA, Sinha R, Richie JP Jr GeroScience\n\nmedical_services Therapy Indications\n\nNovel Biomarkers for Change in Renal Function in People With Dysglycemia. (2019) Gerstein HC, Pare G, McQueen MJ, Lee SF, Bangdiwala SI, Kannt A, Hess A, ORIGIN Trial Investigators Diabetes Care\n\nmedical_services Therapy Indications\n\nSerum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease (2019) Takei N, Suzuki M, Makita H, Konno S, Shimizu K, Kumura H, Kumura H, Nishimura M International Journal of Chronic Obstructive Pulmonary Disease\n\nmedical_services Therapy Indications\n\nBlood-based protein mediators of senility with replications across biofluids (2019) Royall DR, Palmer RF, The Alzheimers Disease Neuroimaging Initiative Brain Communications\n\nmedical_services Therapy Indications\n\nAmygdalar activity predicts future incident diabetes independently of adiposity (2019) Osborne MT, Ishai A, Hammad B, Tung B, Wang Y, Baruch A, Fayad ZA, Giles JT, Lo J, Shin LM, Grinspoon SK, Koenen KC, Pitman RK, Tawakol A Psychoneuroendocrinology\n\nmedical_services Therapy Indications\n\nSOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimers dementia patients (2019) Begic E, Hadzidedic S, Kulaglic A, Ramic-Brkic B, Begic Z, Causevic M PLoS One\n\nmedical_services Therapy Indications\n\nVaccHemInf Project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients (2019) Conrad A, Boccard M, Valour F, Alcazer V, Tovar Sanchez AT, Chidiac C, Laurent F, Vanhems P, Salles G, Brengel-Pesce K, Meunier B, Trouillet-Assant S, Ader F, Lyyon HEMINF Study Group BMJ Journals\n\nmedical_services Therapy Indications\n\nEarly changes in immune, coagulation, and organ function after clinical and experimental polytrauma (2019) Halbgbauer Repositorium der Universit?t Ulm\n\nmedical_services Therapy Indications\n\nTGFb receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer (2019) Melisi D, Garcia-Carbonero R, Macarulla T, Pezet D, Deplangue G, Fuchs M, Trojan J, Kozloff M, Simionato F, Cleverly A, Smith C, Wang S, Man M, Driscoll KE, Estrem ST, Lahn MMF, Benhadji KA, Tabernero J Cancer Chemotherapy and Pharmacology\n\nmedical_services Therapy Indications\n\nExploring and redefining Autoimmune polyendocrine syndrome type 1 (2019) Bruserud Skipnes Kommunikasjon, University of Bergen\n\nmedical_services Therapy Indications\n\nA randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity (2019) Williams PT, Bergeron N, Chiu S, Krauss RM Lipids in Health and Disease\n\nmedical_services Therapy Indications\n\nMaternal deprivation increases microglial activiation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats (2019) Giridharan VV, Gislaine ZR, Selvaraj S, Scaini G, Barichello T, Quevedo J Journal of Psychiatric Research\n\nmedical_services Therapy Indications\n\nPerformance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes (2019) McCarthy CP, Shrestha S, Ibrahim N, van Kimmenade RRJ, Gaggin HK, Mukai R, Magaret C, Barnes G, Rhyne R, Garasic JM, Januzzi JL Open Heart\n\nmedical_services Therapy Indications\n\nVEGF-A from Granuloma Macrophages Regulates Granulomatous Inflammation by a Non-angiogenic Pathway during Mycobacterial Infection (2019) Harding JS, Herbath M, Chen Y, Rayasam A, Ritter A, Csoka B, Hasko G, Michael IP, Faby Z, Nagy A, Sandor M Cell Reports\n\nmedical_services Therapy Indications\n\nSynovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation. (2019) Haraden CA, Huebner JL, Hsueh MF, Li YJ, Kraus VB Arthritis Research & Therapy\n\nmedical_services Therapy Indications\n\nIncreased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis (2019) Cakici N, Bot M, Lamers F, Janssen T, van der Haan L, Bahn S, Penninx BWJH, van Beveren NJM European Neuropsychopharmacology\n\nmedical_services Therapy Indications\n\nNovel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome. (2019) Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R, Shoamanesh A, Gerstein HC, Pare G Circulation\n\nmedical_services Therapy Indications\n\nImmune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial. (2019) Drabe CH, Sorensen SS, Rasmussen A, Perch M, Gustafsson F, Rezahosseini O, Lundgren JD, Osrowski SR, Nielson SD BMC Infectious Diseases\n\nmedical_services Therapy Indications\n\nPlasma cortisol is associated with cerebral hypometabolism across the Alzheimer?s disease spectrum (2019) Wirth M, Lange C, Huijbers W, for the Alzheimers Disease Neuroimaging Initiative Neurobiology of Aging\n\nmedical_services Therapy Indications\n\nIdentifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease. (2019) Fajgenbaum DC, Langan RA, Sada Japp A, Patridge HL, Pierson SK, Singh A, Arenas DJ, Ruth JR, Nabel CS, Stone K, Okumura M, Schwarer A, Jose FF, Hamerschlak N, Wertheim GB, Jordan MB, Cohen AD, Krymskaya V, Rubenstein A, Betts MR, Kambayashi T, van Rhee F, Uldrick TS The Journal of Clinical Investigation\n\nmedical_services Therapy Indications\n\nHypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology (2019) Meyer PF, Savard M, Poirier J, Morgan D, Breitner J, for the Alzheimers Disease Neuroimaging Initiative Alzheimers & Dementia\n\nmedical_services Therapy Indications\n\nImpaired kidney structure and function in spinal muscular atrophy (2019) Nery FC, Siranosian JJ, Rosales I, Deguise MO, Sharma A, Muhtaseb AW, Nwe P, Johnstone AJ, Zhang R, Fatouraei M, Huemer N, Alves CRR, Kothary R, Swoboda KJ Neurology Genetics\n\nmedical_services Therapy Indications\n\nMorphological and Molecular Changes in Juvenile Normal Human Fibroblasts Exposed to Simulated Microgravity. (2019) Buken C, Sahana J, Corydon TJ, Melnik D, Bauer J, Wehland M, Kruger M, Balk S, Abuagela N, Infanger M, Grimm D Scientific Reports\n\nmedical_services Therapy Indications\n\nInnate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment (2019) Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG Schizophrenia Bulletin\n\nmedical_services Therapy Indications\n\nVaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection (2019) Malachowa N, Kobayashi SD, Porter AR, Freedman B, Hanley PW, Lovaglio J, Saturday GA, Gardner DJ, Scott DP, Griffin A, Cordova K, Long D, Rosenke R, Sturdevant DE, Bruno D, Martens C, Kreiswirth BN, DeLeo FR mBio\n\nmedical_services Therapy Indications\n\nAutoinflammatory disease with corneal and mucosal dyskeratosis caused by a novel NLRP1 variant (2019) Herlin T, Jorgensen SE, Host C, Mitchell PS, Christensen MH, Lausten M, Larsen DA, Schmidt FI, Christiansen M, Mogensen TH Rheumatology\n\nmedical_services Therapy Indications\n\nDigital Health: a new dimension in rheumatology patient care (2018) Kataria S, Ravindran V Rheumatology International\n\nmedical_services Therapy Indications\n\nEvaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease (2018) Scaini G, Tonon T, Moura de Souza CF, Schuck PF, Ferreira GC, Quevedo J, Seda Neto J, Amorim T, Camelo Jr JS, Vitoria Barban Margutti A, Hencke Tresbach R, Sperb-Ludwig F, Boy R, V. de Medeiros PF, Schwards IVD, Luiz Streck E Journal of Inherited Metabolic Disease\n\nmedical_services Therapy Indications\n\nA Mul"
    }
}